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ABSTRACT 
 
Sox2 is a master regulator of two distinct cellular states, that of pluripotent embryonic stem cells (ESCs) 
and multipotent neural progenitor cells (NPCs), but what common or distinct roles Sox2 may play in 
these cell types not fully understood.  Further, the molecular mechanisms by which Sox2 can specify two 
distinct cell identities are as of yet unclear.  This thesis is aimed at answering these fundamental 
questions.  In ESCs, Sox2 was associated with a subset of poised regulators of nervous system 
development, and upon differentiation into NPCs Sox2 selectively activates those which are important for 
progenitor cell state, while keeping others poised to become activated in later neural development.  These 
data suggested that Sox2 might act as a pioneer factor for neural development throughout embryogenesis.  
While Sox2 is known to co-occupy target loci in ESCs with the POU factor Oct4, in NPCs Sox2 interacts 
with the central-nervous-system-expressed POU factors Brn1 and Brn2.  By utilizing distinct composite 
Sox:Octamer motifs in each cell type, Sox2:POU modules control the expression of thousands of genes 
involved in the development of the neural lineage in a cell-type-specific manner.  These data advance our 
understanding of the mechanism by which transcription factors control cell fate transitions, and indicate 
that combinatorial interactions between transcription factors may be a pervasive mechanism of 
transcriptional control in development. 
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Preface 
Sox2 is a master regulator of two distinct cellular states, that of pluripotent embryonic stem cells (ESCs) 
and that of multipotent neural progenitor cells (NPCs), but what common or distinct roles Sox2 may play 
in these cell types not fully understood.  Further, the molecular mechanisms by which Sox2 can specify 
two distinct cell identities are as of yet unclear.  This thesis is aimed at answering these fundamental 
questions.  In Chapter 1, I will introduce important concepts for understanding this body of work.  Next, 
in Chapter 2 I will outline the functional role of Sox2 in ESCs and NPCs, namely that Sox2 occupied both 
proximal promoter regions and a large group of distal enhancer regions in both cell types.  I also will 
present data that suggests how Sox2 can function in a context-specific manner in ESCs and NPCs.  While 
Sox2 is known to co-occupy target loci in ESCs with the POU factor Oct4, in NPCs Sox2 interacts with 
the central-nervous-system-expressed POU factors Brn1 and Brn2.  By utilizing distinct composite 
Sox:Octamer motifs in each cell type, Sox2:POU modules control the expression of thousands of genes in 
a cell-type-specific manner.  In the following Supplemental Chapter, I will present additional data I 
generated which delves deeper into the detailed genome-wide binding pattern of Sox2 in ESCs and NPCs.  
Specifically, while Sox2-bound regions in ESCs and NPCs were distinct, they were often linked to 
enhancers of the same genes.  These genes tended to be involved in neural development, and while Sox2 
was associated with poised enhancers of these loci in ESCs, upon differentiation into NPCs Sox2 
associated with active enhancers of those genes which are important for NPC state, while associating with 
new poised enhancers of genes with the potential become activated in later neural development.  These 
data suggested that Sox2 might act as a pioneer factor for neural development throughout embryogenesis.  
These data advance our understanding of the mechanism by which transcription factors control cell fate 
transitions, and indicate that combinatorial interactions between transcription factors may be a pervasive 
mechanism of transcriptional control in development. 
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Chapter I: Introduction 
Abstract 
Sox2 is a master regulator of several tissue specific stem/progenitor cells, yet how Sox2 controls distinct 
stem cell identities is not fully understood.  This thesis will explore the genome-wide targets of Sox2 in 
two such populations, pluripotent embryonic stem cells (ESCs) and multipotent neuronal progenitor cells 
(NPCs).  It is important to define the role of master regulatory transcription factors such as Sox2 in 
controlling cell identity because these factors have been shown to be central to defining the molecular 
characteristics of a cell.  In order to facilitate a full appreciation of the data presented in later chapters, 
this introductory chapter will first discuss transcription factors and the mechanisms by which they control 
cell state, then introduce key concepts in ESC and NPC biology.  Next, I will review the known roles of 
Sox2 in early development, specifically in ESCs and the partnership between Sox2 and the POU factor 
Oct4.  I will then discuss the known roles of Sox2 in the developing and adult nervous system.  I found 
that Sox2 co-occupied a large subset of enhancers in NPCs with the central-nervous-system-expressed 
POU factors Brn1 and Brn2, similarly to its interaction with Oct4 in ESCs. Therefore, I will end this 
introduction with a review of what is known about the function of these POU factors in the developing 
nervous system.  
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Transcription Factors Control Gene Expression Programs 
Master Regulators are a special class of transcription factors which control cell identity 
Transcription factors bind to DNA in a sequence specific manner and regulate which genes in the 
genome will be expressed in a given cell type, and thus are thought to sit at the top of a hierarchy 
controlling cellular identity.  Master regulators comprise a special class of transcription factors which are 
especially potent regulators of cell state.  In their associated cell type, master regulators are typically 
highly expressed and bind thousands of genomic targets involved in cellular identity (Young, 2011).  For 
example, in embryonic stem cells (ESCs), master regulatory transcription factors such as the HMG-box 
containing factor Sox2 control both the ESC cell identity and set the stage for later developmental 
transitions (Boyer et al., 2005; Loh et al., 2006, below).   Master regulators are typically necessary for the 
establishment and maintenance of cell state in vivo, and the potency of master regulatory transcription 
factors is perhaps best exemplified by the ability of a master regulator of one cell type to reprogram 
cellular identity when expressed ectopically in another cell type.  For example, the transcription factor 
MyoD is a master regulator of muscle development, and when MyoD is ectopically expressed in 
fibroblast cells it can completely reprogram them into myotubes (Lassar et al., 1986).  Similarly, ectopic 
expression of master regulatory transcription factors of other cell types have the ability to induce 
reprogramming by forcibly establishing their own cell-type-specific gene expression programs (Xie et al., 
2004; Takahashi and Yamanaka, 2006; Feng et al., 2008; Seale et al., 2008; Zhou et al., 2008; Kim et al., 
2011).  Thus, master regulatory transcription factors are strong regulators of cell state. 
Molecular mechanisms of transcription factor action 
Transcription factors modulate transcriptional activity by recruiting the transcriptional apparatus 
to specific loci.  Generally, a transcription factor is comprised of a DNA-binding domain and one or more 
transactivation domains, which mediate interactions with other proteins.  Mechanistically, a stable 
interaction between the DNA-binding domain of a transcription factor with a genomic DNA target 
provides an interface at that locus for interactions between its transactivation domains and other factors, 
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which then affect transcriptional activity.  These other factors include protein complexes which modify 
chromatin structure and covalently mark histone tails, including histone methyltransferases (and 
demethylases), acetyltransferases (and deacetylases), and enzymes which catalyze a host of other histone 
modifications (Bannister and Kouzarides, 2011; Tan et al., 2011; Meurs, 2011).  Modified histone tails in 
turn serve as docking sites for effector proteins containing domains which recognize these specific 
modifications, such as chromodomains which recognize methylated lysines, and bromodomains which 
recognize acetylated lysines. Once properly localized, these proteins  then act to regulate transcriptional 
activity (Kouzarides, 2007).  Transcription factors also interact with co-activator protein complexes such 
as the mediator, which interact directly with the basal transcriptional apparatus to recruit the RNA 
polymerase II transcription initiation complex (Lee and Young, 2000).  It has recently become clear that 
transcriptional initiation is only one step at which transcription factors act.  A significant amount of 
regulation takes place at the transition from initiation to transcriptional elongation, and transcription 
factors such as c-Myc play a major role in releasing paused polymerase by recruiting release factors such 
as p-TEFb to promoters (Rahl et al., 2010).  Thus, transcription factors play a central role in regulating the 
activity of promoters by recruiting co-activators and the transcriptional apparatus to these regions.  
While a large part of transcriptional regulation occurs at proximal promoters, regions far from 
transcription start sites, known as distal enhancers, also play a critical role in modulating gene expression 
levels.  In addition to regulating promoters directly, transcription factors also play a role in regulating 
these distal elements to control gene expression at a distance. 
Distal enhancers control gene expression at a distance 
 Transcriptional control in Eukaryotes is a complex biological process involving proximal 
promoters, trans-acting protein and RNA factors, and importantly distal cis-regulatory elements called 
enhancers (Müller et al., 1988).  Enhancers regulate transcriptional initiation at promoters from distances 
of several hundred base pairs to 1 Mb away from target transcriptional start sites (TSSs) (Lewin, 2008).  
Two general models of the role of enhancers have been proposed and validated in vivo: firstly, enhancers 
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can increase the expression of an already active promoter, or secondly an enhancer may activate 
expression of a primed but inactive promoter (Blackwood and Kadonaga, 1998).  One of the first 
described enhancers was discovered in the genome of the polyomavirus SV40; when this sequence was 
linked to a test gene in a heterologous reporter assay it increased transcription by over 100-fold, even 
from distances as great as 3 kb (Banerji et al., 1981).  Soon after, many other enhancers were discovered 
using heterologous reporter assays and enhancer trap techniques (O'Kane and Gehring, 1987; Brand and 
Perrimon, 1993; Kaiser, 1993).  Enhancer discovery progressed rapidly with the advent of genome-wide 
analysis methods (Sakabe et al., 2012).  The sequencing of the human and mouse genomes led to the 
realization that the vast majority of the DNA is non-protein coding, and while first hypothesized to be 
“junk DNA”, it is now becoming clear that much of the non-coding mammalian genome is regulatory and 
contains many functional enhancer elements (Visel et al., 2009).  For example, non-coding elements 
which are highly conserved between species have been shown to be enriched for functional, tissue-
specific enhancers (Pennacchio et al., 2006).  Further, genome-wide maps of chromatin state generate 
using ChIP-Seq (Figure 1) have shown that specific histone modifications are enriched far from 
promoters and associated with distal enhancers (Heintzman et al., 2007, 2009; Creyghton et al., 2010; 
Rada-Iglesias et al., 2011).  Specifically, monomethylation of Lysine 4 of Histone H3 (H3K4me1) and 
acetylation of Lysine 27 of Histone H3 (H3K27Ac) have been shown to mark poised (H3K4me1+, 
H3K27Ac-) and active (H3K4me1+/H3K27Ac+ or H3K4me1-/H3K27Ac+) enhancers.  Genes linked to 
active enhancers were shown to be preferentially expressed in the cell type in which the enhancers were 
marked, while those near poised enhancers were shown to be expressed in stimulus-dependent ways, such 
as upon differentiation.   Thus, transcriptional regulation by enhancers is a conserved and widespread 
genomic phenomenon. 
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Figure 1 
                                      
Figure 1-Schematic of a chromatin immunoprecipitation followed by massively parallel sequencing 
(ChIP-Seq) experiment.  Cross-linked chromatin is isolated (1) and sheared into fragments (2), then 
specific antibodies are used to immunoprecipitate proteins of interest and associated genomic DNA (3).  
Next, genomic DNA is purified away from bound protein and subjected to high-throughput short-read 
sequencing (4).  When these reads are mapped back to a reference genome, regions enriched by ChIP can 
be identified and thus genomic targets of a given factors can be defined.  ChIP-Seq has become a crucial 
tool for studying genome-wide binding profiles of many sequence-specific transcription factors, 
chromatin regulators, and modified histones.  Modified from Szalkowski and Schmidt, 2011. 
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Transcription Factors Regulate Enhancer Activity  
Transcription factors are key regulators of distal enhancers.  Enhancers are typically comprised of 
multiple transcription factor binding sites, each of which are essential for function of the element (Lewin, 
2008).  The classic example of this phenomenon is the IFN-β enhancesome, which is a protein complex 
comprised of the structural protein HMG1 and sequence-specific transcription factors including NF-κB, 
IRF, ATF-Jun, and others (Maniatis et al., 1998).  The recognition sites for all of these factors are 
essential to the activity of this element.  These factors cooperatively bind to the IFN- β enhancer and then 
activate this element which positively regulates IFN- β promoter activity.  Interestingly, in ESCs the vast 
majority of TSS-distal regions co-bound by Oct4, Sox2 and Nanog tested performed as enhancers in 
heterologous reporter assays.  Further, proteomic data suggested that these factors interact physically with 
each other.  These data suggest that the core-regulatory circuitry of ESCs may also function as an 
enhancesome (Kim et al., 2008; Chen et al., 2008).  Generally, when transcription factors bind enhancers, 
they act as activators and recruit co-activators to enhancer elements (Figure 2).  Mechanistically, 
enhancers physically interact with promoters to achieve regulatory function though looping of DNA 
sequences separating them (Mueller-Strum et al., 1989; Zhao and Dean, 2005; Fullwood et al., 2009).  
These loops deliver transcriptional co-activators to promoters, which in turn recruit the transcriptional 
machinery, including RNA polymerase (Figure 2).  Thus, enhancers function by interacting with 
sequence-specific transcription factors, which then recruit co-activators or the transcriptional machinery 
itself, then finally physically loop to promoters to deliver these molecules, thus activating transcription. 
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Figure 2 
 
Figure 2-Enhancers loop DNA to deliver co-activators to promoters.  The core transcriptional 
machinery, including basal transcription factors (labeled A, B, F, E, and H) and TATA-binding protein, is 
essential for transcription but cannot by itself increase or decrease its rate. That task falls to regulatory 
molecules such as activators, including sequence-specific transcription factors, which bind to regulatory 
elements such as enhancers and recruit co-activators, such as the Mediator complex.  Then, DNA looping 
allows the co-activators to be delivered to core promoters, where they communicate with basal factors and 
activate transcription. Other elements such as silencers interact with repressors to negatively regulate 
transcription.  Adapted from Griffiths et al., 2000. 
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Pioneer Factors Regulate Enhancers in Development 
Transcription factors also influence enhancer activity by other mechanisms.  The binding of 
enhancer regions by transcription factors is thought to depend in some part on the occupancy of the DNA 
sequence by nucleosomes, which can occlude transcription factor binding sites.  Transcription factor 
binding at enhancers may be facilitated by the relatively nucleosome-depleted status of these elements, as 
evidenced by their hypersensitivity to DNAse treatment (Shones 2008; He et al., 2010).  Intriguingly, this 
nucleosome depletion is thought to be first set-up by a special class of transcription factors called pioneer 
factors (Smale, 2010).  These factors, such as the those belonging to the FoxA subgroup of the forkhead 
transcription factor family, are thought to bind DNA motifs in a non-histone-sensitive manner and evict 
nucleosomes from enhancers, which can then be bound by other effector transcription factors to activate 
transcription (Kaestner, 2010).  In both ESCs and NPCs, Sox2 is known to bind a large number of sites in 
the genome linked to non-expressed genes, which later in development become bound by other factors 
and expressed (Boyer et al., 2005; Loh et al., 2005; Chen et al., 2008; Marson et al., 2008; Liber et al., 
2010; Bergsland et al., 2011), suggesting that Sox2 may be a pioneer factor.  Thus, sequence specific 
transcription factors may prime enhancer elements for later activation. 
Sox2 is a master regulator of two distinct cellular states, that of pluripotent ESCs and multipotent 
NPCs.  In order to allow for a comprehensive understanding of the role of Sox2 in these cells, I will first 
introduce key concepts in ESC and NPCs biology, and then return to the role the transcription factor Sox2 
may play in each of these cell types 
Embryonic Stem Cells and Neural Precursor Cells:  
Two Stem Cell Types with Distinct Characteristics 
Embryonic Stem Cells 
 Embryonic stem cells have been intensely studied for over three decades and since their discovery 
(Evans and Kaufman, 1981; Martin, 1981) and have become vital tools for studies in development, mouse 
genetics, and disease modeling.  ESCs are the in vitro derivative of the inner cell mass (ICM) of the 
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mammalian blastocyst, and like the cells of the ICM ESCs are pluripotent, meaning they have the 
potential to give rise to all of the cell types of the embryo proper.  When ESCs are injected back into host 
blastocysts, they can participate in development and have the potential to give rise to an entire adult 
mouse, including the germ cells (Bradley et al., 1984; Nagy et al., 1990).  Due to this unique property, 
ESCs have been instrumental in the field of mouse genetics.  Gene targeting of ESCs by homologous 
recombination and subsequent injection of targeted cells into blastocysts has made it possible for 
hundreds of knock-out and reporter mice to be studied (Doetschman et al., 1987; Thomas and Capecchi, 
1987).  Further, ESCs can be induced to differentiate in vitro, allowing for defined and accessible analysis 
of cell fate transitions in early development.  The isolation of human ESCs focused much attention on the 
ability of these cells to play a role in regenerative medicine and human disease modeling; given that 
mouse ESCs have the potential to develop into any adult cell type, hESCs are thought to be a viable 
source for both tissue replacement therapy and disease modeling (Thompson et al., 1998; Mountford, 
2008).  Due to these distinctive properties, ESCs have been subjected to virtually every level of analysis 
from studies of individual molecular interactions to large scale genomic and proteomic studies (Young, 
2011).  Thus, ESCs are a well-characterized and important model of development. 
 Multiple extracellular signaling pathways have been shown to affect the ESC state.  ESCs were 
originally derived in serum-containing medium in the presence of feeder cells, mouse embryonic 
fibroblasts (MEFs).  The specific signals provided by serum and MEFs were soon identified and provided 
insights into the molecular characteristics of the ESC state.  The primary effector though which serum 
supports ESCs is the bone morphogenetic protein BMP4, which signals to inhibitor of differentiation (Id) 
genes through the BMP effectors, SMADs (Ying et al., 2003).  Other important factors in serum include 
Wnt proteins, and the activity of the Wnt pathway has been shown to inhibit differentiation of mouse 
ESCs (Kielman et al., 2002; Ogawa et al., 2006).  The primary function of MEFs is to secret leukemia 
inhibitory factor (LIF) (Williams et al., 1988; Smith et al., 1988).  LIF signaling is essential for ESC 
maintenance, and is thought to function by binding to LIF receptor causing it to dimerize with gp130, 
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leading to activation of the transcription factor Stat3 (Niwa et al., 1998).  Part of the function of Stat3 is to 
counteract the function of FGF4, which is produced by ESCs in an autocrine manner.  By signaling 
through FGFR, FGF4 activates the MAPK-pathway mediators ERK1 and ERK2, which promote 
differentiation of ESCs (Kunath et al., 2007).  LIF also signals to the core-regulatory transcription factor 
network in ESCs which consists of Oct4, Sox2, and Nanog (see below) through Stat3 and the kinase Akt 
(Niwa et al., 2009).  These data eventually allowed Austin Smith and colleagues to derive and grow 
mouse ESCs in completely defined chemical medium containing LIF and inhibitors of ERK signaling and 
GSK3β, a negative regulator of the Wnt pathway, a condition called “2i + LIF” (Ying et al., 2008).  LIF 
could be omitted from the growth medium if a pharmacological inhibitor of FGF signaling was added in 
its place; this growth condition was called “3i” because it relied on these three inhibitors.  Cells grown in 
2i + LIF or 3i are fully pluripotent and self-renew indefinitely.  Thus, the inputs of multiple signaling 
pathways are integrated by ESCs to make the developmental decision whether to remain in the ESC state 
or differentiate. 
Neural Precursor Cells 
 During development, neural stem/progenitor cells (abbreviated NPCs herein) give rise to cells of 
the central nervous system (CNS).  In the mouse, neural development begins after gastrulation when the 
ectoderm further develops into three tissues: the epidermis, which will form the skin; the neural crest, 
which will migrate to form the peripheral nervous system; and the neural tube, which is destined to form 
the brain and spinal cord, collectively known as the central nervous system (CNS) (Gilbert, 2000).   As 
development proceeds, cells which remain closest to the lumen at the interior of the neural tube remain 
mitotic and give rise to neurons, astrocytes, oligodendrocyes, and in addition can self-renew.  As the brain 
develops, these cells occupy specific regions of the developing brain, such as the subventricular zone of 
the cortex and the subgranular layer of the hippocampus.  These cells are therefore known as neural stem 
cells or neural progenitor cells (NPCs) (Reynolds and Weiss, 1992; Davis and Temple, 1994; Gritti et al., 
1996; Reynolds and Weiss 1996).  As development of the CNS proceeds, NPCs exhibit a progressive 
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restriction of developmental potency; early on, NPCs become regionally specified along the 
anterior/posterior axis, and as development progresses NPCs give rise to specific cell types destined for 
specific subregions of the CNS in a temporally specific manner (Molyneaux et al., 2007).  This program 
is thought to be intrinsic to the NPCs themselves (Qian et al., 2000; Shen et al., 2006).  It was 
traditionally believed that the number of cells in the brain is fixed at a certain developmental stage, and 
that no mitotic cells exist in the adult brain. Work by Altman suggested the existence of mitotic cells in 
specific regions of the rat and feline brain, but it was not until later work in songbirds and mice that the 
existence of actively dividing cells in the adult brain was fully accepted (Altman, 1962, 1963, 1969, 
Goldman and Nottelbohm, 1983; Paton and Nottelbohm, 1984; Lois and Alvarez-Buylla, 1993; Johansson 
et al., 1999).  In the adult brain, NPCs are also found in the subventricular zone and the subgranular layer, 
and adopt a radial glial morphology (Doetsch et al., 1999).  Adult NPCs have mitotic and self-renewal 
potential, but remain quiescent for long periods of time, thus explaining the limited regenerative potential 
in the adult brain.  Thus, NPCs are involved in the embryonic development of and adult maintenance of 
the CNS. 
Multiple extracellular signaling pathways play a role in the development and function of NPCs.  
In fact, changes in the phenotype and developmental potential of mouse NPCs through ontogeny and into 
adulthood are accompanied by, and possibly driven by, changes in the responsiveness to extracellular and 
intracellular signals (Temple, 2001).  For example, while mouse NPCs in the early embryo do not respond 
to EGF signaling, those isolated from late mouse embryos and adults rely on EGF signaling to proliferate 
(Gritti et al., 1999; Tropepe et al., 1999; Qian et al., 2000).  Also, while early NPCs differentiate into 
neurons upon signaling BMPs, late embryonic NPCs commit to the astrocytic lineage in response to BMP 
signaling (Mehler et al., 2000).  In the adult, the extracellular inhibitor of BMP signaling, Noggin, blocks 
this pathway to allow adult NPCs to again generate new neurons (Lim et al. 2000).  In general, adult 
NPCs are thought to exist in a perivascular niche, where they are supported by endothelial cells which 
secrete factors which support the NPC state such as bFGF (Palmer et al., 2000; Shen et al 2004).  Other 
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external signaling pathways, such as Wnt, Notch, and Sonic Hedgehog have been shown to be necessary 
for the function of NPCs in context specific ways and therefore the proper execution of neural 
development (Lai et al., 2003; Zhou et al., 2004; Yoon et al., 2005; Lie et al., 2005).  Thus, NPCs are 
regulated at multiple levels to ensure proper execution of nervous system development. 
The differential responses to and requirements for extracellular signals are thought to be the result 
of epigenetic changes in NPCs mediated by transcription factors over developmental time (Qian et al., 
2000; Shen et al., 2006; Hirabayashi and Gotoh, 2010).  Transcriptional regulators such those belonging 
to the Sox, Fox, POU and Hes families play critical roles in the maintenance of NPC identity at specific 
times by actively regulating the stem cell program and, in the case of Hes1 and Hes5, directly 
counteracting the function of pro-differentiation bHLH transcription factors such as Mash1, Math1, and 
Neurogenin (Ohtsuka et al., 1999, 2001; Ferri et al., 2004; Kageyama et al., 2005; Castro et al., 2006).  
These sequence-specific transcription factors activate gene expression programs by recruiting co-activator 
and co-repressor complexes which modify DNA and histones at specific loci, such as the bithorax group 
protein MLL1 and the Polycomb group protein Bmi1, both of which have been shown to affect NPC self-
renewal (Molofsky et al., 2003; Lim et al., 2009).  For example, in early neocortical development, NPCs 
do not respond to JAK-Stat signaling, but do respond to Wnt signaling by activating proneural 
transcriptional factors such as Ngn1, which then induce their differentiation to neurons.  Later, Wnt 
signals are not able to induce neural differentiation, while JAK-Stat signaling induces astrogliogenesis.  
This switch was found to be mediated by DNA and histone methyltransferases which reversibly silenced 
proastroglial and proneural programs at specific developmental stages and rendered the cells responsive 
to certain signals but not others (Sun et al., 2001; Guillemot, 2005).  Thus, a combination of extracellular 
signals and epigenetic changes control the progression of NPC competence though development. 
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The Role of the Transcription Factor Sox2 in Development  
Sox2 is a member of a large family of developmental regulators 
Sox2 (SRY-box 2) is part of the Sox family, a large group of sequence-specific, developmental 
regulatory transcription factors.  The group comprises over 30 members identified across metazoans, 20 
of which are conserved in mammals (Bowles et al., 2000; Keifer et al., 2007).  Sox2 is part of the SoxB1 
subfamily, along with Sox1 and Sox3, and is conserved from flies to humans (Soriano and Russell, 1998; 
Bowles et al., 2000).  The Sox family was discovered by searching cDNA libraries for sequences 
homologous to the HMG domain of the male sex-determining factor, Sry (Sinclair et al., 1990; Gubbay et 
al., 1990; Denny et al., 1992; Wright et al., 1993).  The HMG domain is the sequence-specific DNA-
binding domain of Sox proteins; the name HMG is derived from the homology this domain has to the 
DNA binding domains of the high mobility group proteins HMG1 and HMG2, which bind DNA in a non-
sequence specific manner and are thought to play architectural roles in chromatin (Thomas, 2001).  All 
Sox family members are defined as being at least 50% identical in their HMG domain to Sry.  Sox 
transcription factors play diverse roles in development, and as a group have been shown to be crucial for 
the genesis of many major organ systems in mammals (Lefebrve et al., 2007).  Thus, defining the function 
of specific Sox family members such as Sox2 is key to understanding metazoan development in general. 
 Sox2 was one of the earliest identified Sox family members (Denny et al., 1992 (1); Wright et al., 
1993).  The Sox2 locus exists on Chromosome 3 in the mouse genome, and contains a single exon.  It 
encodes a 2.5kb mRNA, the expression of which in the embryo generally marks cell types with the broad 
developmental potential.  Sox2 is expressed in the unfertilized oocyte, and after fertilization it is activated 
in the embryonic genome during the maternal-to-zygotic transition (Avillion et al., 2003, Zeng and 
Shultz, 2005; Pan and Shultz, 2011).  It is also highly expressed in the inner cell mass (ICM), epiblast and 
extraembryonic endoderm in the peri-implantation embryo (Wood and Episkopou, 1999; Avillion et al., 
2003).  After gastrulation, Sox2 expression becomes restricted to the prospective ectoderm, neural plate 
and the chorion (Wood and Episkopou, 1999; Zappone et al., 2000; Avillion et al., 2003).  During 
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somitogenesis, Sox2 is expressed highly in the neurectoderm, including the primitive streak, and also 
marks the genital ridge, gut endoderm, prospective sensory placodes, and the brachial arches (Collignon 
et al., 1996; Wood and Episkopou, 1999; Avillion et al., 2003).  Sox2 mRNA is translated into a 39kDa 
protein containing an HMG DNA binding domain in its N-terminal region.  The Sox2-HMG domain 
binds to DNA sequence specifically in the minor groove, and like other HMG domains the Sox2-HMG 
domain causes a dramatic bend in the double helix at the point of contact, which is essential for function 
(Kamachi et al., 1999; Scaffidi et al., 2001; Remenyi et al., 2003; Williams et al., 2004).  The C-terminal 
region of Sox2 contains modular transactivation domains which mediate interactions with transcription 
factor partners such as Oct4 to stabilize DNA binding and with histone modifiers such as the histone 
acetyltransferase p300 to affect transcriptional activation (Nowling et al., 2000; Ambrosetti et al., 2000) 
Sox2 interacts with partner factors to control gene expression programs 
Transcription factors bind to DNA to recruit the transcriptional machinery to specific loci, and 
often more than one transcription factor binds to a given locus at the same time.  By binding in different 
combinations with one another, transcription factors provide the cell with a diverse toolbox of 
stereochemical interfaces which may be integrated differentially by the transcriptional apparatus.  In this 
way, transcription factors can to specify distinct gene expression programs utilizing the small number of 
transcription factors (about 2000) encoded in the genome to regulate all genes (20,000) across 200 cell 
types during development and in the face of a host of external stimuli (Remenyi et al., 2004). 
The Sox protein family interacts with several other transcription factor families to control gene 
expression.  This is partially necessary for Sox proteins because partner factor interactions have been 
shown to stabilize them on DNA targets, for which they have relatively low binding affinity relative to 
other transcription factors (KD = approximately 10
-9
 M for Sox-HMG compared to 10
-11 
M to 10
-12 
M for 
other transcription factors) (Kamachi, 2000).  Sox2 has been shown to interact with a number of other 
factors in this way.  In the developing lens, Sox2 has been shown to interact with the paired box 
transcription factor Pax6 and the bZIP transcription factor Maf to cooperatively bind to and regulate 
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crystalline gene expression (Kamachi et al., 2000; Shimada et al., 2003).  Further, Sox2 and Pax6 have 
been shown to regulate Sox2 expression by binding to a distal enhancer of the Sox2 locus in the lens 
(Inoue et al., 2007).  Perhaps one of the most important classes of partner factors for Sox proteins is the 
POU-homeobox family of transcription factors; the interaction between Sox and POU family members is 
conserved across metazoans from Drosophila melanogaster and Caenorhabditis elegans to mammals 
(Dailey and Basilico, 2001).  Many Sox:POU modules have been described which cooperatively control 
gene expression in the mouse (Ambrosetti et al., 1997; Botquin et al., 1998; Kuhlbrodt et al., 1998; 
Tomioka et al., 2002; Remenyi et al., 2003; Tanaka et al., 2003; Donner et al., 2007; Reiprich et al., 
2010),  including the well characterized interplay between Sox2 and Oct4 in ESCs (below).  In general, 
Sox:POU interactions are thought to stabilize binding to DNA targets and result in synergistic activation 
of target loci.  Thus Sox proteins, and Sox2 in particular, utilize interactions with partner factors to 
achieve regulatory functions in many systems. 
The role of Sox2 in early development 
Effects of Sox2 loss-of function in vivo 
 Given the expression pattern of Sox2 in the early embryo and in vitro derivatives thereof, much 
interest was focused on defining the functional role of Sox2 during development in vivo.  Therefore, a 
Sox2 loss-of-function allele was generated (Avillion et al., 2003).  Animals heterozygous for this allele 
were grossly normal, save for a minor, background dependent decrease in male fertility.  Sox2 
homozygous null embryos failed around implantation; while Sox2-null blastocysts appeared normal, 
defects which manifested shortly after implantation resulted in a failure to properly form an epiblast, an 
embryonic tissue which is destined to give rise to all the tissues of the adult.  Moreover, the inner cell 
mass (ICM) of these blastocysts failed to outgrow in culture into stable embryonic stem cell (ESC) lines.  
The ability of these embryos to form a phenotypically normal but ultimately nonfunctional ICM is 
attributed to the persistence of maternal stores of Sox2 mRNA and protein.  Inspection of failed 
implantation sites derived from heterozygous intercrosses (presumed to be the remains of failed Sox2-null 
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embryos) revealed that while Oct4-positive epiblast cells were absent, disorganized H19-positive and 
Evx1-positive tissue were present, indicating that Sox2 is not necessary for early extraembryonic 
lineages, and that early non-epiblast ICM derivatives such as visceral endoderm were formed.  
Presumably, lack of signaling from a functional epiblast caused these tissues to fail to develop further.  To 
test this, wild type ESCs were injected into Sox2-null blastocysts. While these cells were able to rescue 
the early embryonic lethality of these embryos, they still did not yield viable full-term fetuses.  Thus, 
while Sox2 is dispensable for early extraembryonic lineages, it may function in later extraembryonic 
tissues, such as extraembryonic ectoderm, the chorion, trophoblast cells, and the placenta, where 
expression of Sox2 is indeed detected.  Therefore, Sox2 is essential for mouse embryogenesis, both 
though the regulation of early, pluripotent, embryonic lineages and possibly by regulating later, 
extraembryonic tissues. 
Role of Sox2 in ESCs 
 Since ESCs could not be derived from Sox2-null embryos, the loss-of-function phenotype in 
Sox2-null ESCs was addressed using a conditional knockout/inducible transgene strategy (Masui et al., 
2007).  In this system, both alleles of Sox2 were targeted with constructs which flanked the coding region 
with LoxP sites.  Then, an inducible Sox2 transgene was introduced into these cells.  Finally, Cre 
expression was induced to cause recombination of the Sox2 flanking LoxP sites resulting in loop-out of 
the coding sequence; simultaneously Sox2 transgene expression was induced, yielding ESCs dependent 
on this inducible Sox2 expression.  Once expression of this transgene was turned off, the phenotype of 
acute loss of Sox2 in ESCs could be assessed.  Loss of Sox2 expression caused ESCs to transdifferentiate 
into trophoblast-like cells, a fate which wild-type ESCs, ICM, and epiblast do not adopt (Beddington et 
al., 1989).  This is the same phenotype as loss-of-function of Oct4 (Niwa et al., 2000), suggesting these 
factors control similar pathways.  A similar result was obtained by another group, using a Sox2 dominant 
negative strategy (Li et al., 2007).  While these Sox2-null ESCs could not be maintained and rapidly 
down-regulated many Sox2 targets such as Oct4, not all Sox2 target genes were immediately and fully 
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down regulated.  This was due to compensation by other Sox factors expressed in ESCs, including Sox4, 
Sox11, and Sox15.  Forced expression of Oct4 could rescue many of the defects of these ESCs by 
partnering with these other Sox factors, allowing Sox2-null ESCs to contribute to late stage chimeric 
embryos, although the viability of these embryos to term was not addressed.  Thus, ESCs depend on Sox2 
function to maintain pluripotency. 
Sox2 and Oct4 co-operate to globally regulate ESC state 
The first Sox2 target identified was an enhancer of the Fgf4 locus in embryonic carcinoma cells 
(ECCs), an element which it co-regulates with Oct4.  Studies of Sox family members identified general 
features of Sox binding to DNA targets (Nasrin et al., 1991; Denny et al., 1992 (2)), and using these data 
it was possible to scan regulatory regions of genes for candidate binding sites for Sox2.  In ECCs, the 
Fgf4 locus was known to be under the control of an intronic enhancer element containing an Octamer 
motif, the recognition site for the POU family of transcription factors (Curatola et al., 1990).  This 
element was bound by the POU factors Oct1 and Oct3 (later renamed Oct4), in complex with another 
nuclear factor, provisionally named Fx (Dailey et al., 1994).  The assembly of this ternary complex was 
dependent on a sequence nearby the Octamer motif, 5’-CTTTGTT-3’ which was noted to be similar to the 
previously identified Sox motif.   Using a degenerate PCR approach to amplify cDNAs homologous to 
the Sry HMG domain, Sox2 was found to be expressed in ECCs and it was identified as factor Fx (Yuan 
et al., 1995).  The interaction between Sox2 and Oct4 at the Ffg4 intronic enhancer was shown to result in 
cooperative binding to DNA and synergistic activation of this enhancer (Figure 3), a paradigm which 
would later manifest itself at many Sox2:Oct4 targets and further at many Sox:POU targets in other 
tissues. 
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Figure 3 
 
Figure 3: Synergistic activity of Sox2 and Oct4 at an FGF4 enhancer.  a. Schematic of control (left) 
and heterologous, FGF4-enhancer-driven (right, white rectangle) chloramphenicol acetyltransferase 
(CAT) reporter constructs.  Black box, Sox2 binding site; gray box, Oct4 binding site; white box, binding 
site for another transcription factor, Sp1; white circle, TATA box; hashed box, CAT CDS.  b. Ectopic 
Sox2, Sox5, Oct4, and Oct1 show limited ability to induce expression of this reporter alone, but Sox2 and 
Oct4 synergistically activate CAT expression when transfected together.   Adapted from Yuan et al., 
1995. 
 
 The partnership observed between Sox2 and Oct4 in ECCs was confirmed in ESCs at many target 
loci, and is mediated through defined domains in the DNA binding and transactivation regions of the 
Sox2 and Oct4 proteins.  In addition to Fgf4, they have been shown to cooperatively bind and 
synergistically activate numerous targets in ESCs, including UTF1, ZFP206, and Lefty1 (Nishimoto et al., 
2005; Nakatake et al., 2006; Wang et al., 2007).  Crystal structures of the HMG domain of Sox2 in 
complex with the POU domain of the Oct4 family member Oct1 at two genomic targets (enhancers of 
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Fgf4 and HoxB1) suggested that specific residues within the DNA binding domains of these proteins were 
critical for complex stabilization (Remenyi et al., 2003; Williams et al., 2004).  Other studies of regions 
outside the HMG and POU domains of Sox2 and Oct4 demonstrated that non-DNA binding domains in 
the C-terminus of Sox2 (region R3) and in the C-terminus of Oct4 (region AD2) were modular 
transactivation domains which functioned to stabilize Sox2:Oct4:DNA complex formation, while other 
domains were defined (R1, R2, AD2) which are transactivating but not involved in this interaction 
directly (Ambrosetti et al., 2000).  Thus, Sox2:Oct4 co-regulate many targets in ESCs through extensive 
protein: protein interactions which stabilize them on genomic targets. 
Sox2:Oct4 co-regulation is a critical genome-wide phenomenon in ESCs.  Genomic studies 
showed that Sox2 and Oct4 (along with the divergent homeodomain protein Nanog) co-occupy thousands 
of genomic target sites near promoter regions in mouse and human ESCs (Boyer et al., 2005; Loh et al., 
2006) (Figure 4).  Genes bound by Sox2:Oct4 included many regulators of pluripotency and the ESC 
state, including Oct4, Sox2, and Nanog themselves, indicating that these factors form an autoregulatory 
loop (Boyer et al., 2005; Chew et al., 2005; Okumura-Nakanishi et al., 2005; Kuroda et al., 2005; Rodda 
et al., 2005; Loh et al., 2006).  Surprisingly, Oct4, Sox2, and Nanog also occupied lineage commitment 
factors which were repressed in ESCs (Figure 4).  These repressed genes were demonstrated to be marked 
by the Polycomb repressive complex with trimethylation of Lysine 27 on Histone H3 (H3K27me3), a 
well characterized mechanism in gene silencing (Lee et al., 2006; Boyer et al., 2006).  Later, whole 
genome studies allowed Sox2- and Oct4-occupied sites distal to TSSs to be mapped (Marson et al., 2008; 
Chen et al., 2008).  These studies demonstrated that the vast majority of Sox2 targets in ESCs are co-
occupied by Oct4, and that a large fraction of genomic loci bound by these factors are distal to 
transcriptional start sites.  Further, when tested in heterologous reporter assays these distal regions behave 
as enhancers.  Taken together with proteomic interaction data (Kim et al., 2008), this suggests that Sox2 
and Oct4 may be at the center of an ESC-specific enhancesome which controls ESC identity.  The 
potency of Sox2 and Oct4 to enforce the ESC state was definitively demonstrated in 2006, when 
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Takahashi and Yamanaka showed that the ectopic expression of four transcription factors, Oct4, Sox2, 
Klf4 and c-Myc could completely reprogram a somatic epigenome back to a pluripotent ESC-like state 
(Takahashi and Yamanaka, 2006, see below).  Thus, the Sox2:Oct4 partnership sits at the center of a core-
regulatory network controlling ESC identity. 
Figure 4 
 
Figure 4: Sox2, Oct4, and Nanog form an autoregulatory loop which controls ESC pluripotency.  
Sox2, Oct4, and Nanog occupy regulatory regions of genes involved in both ESCs identity (top), 
including Pou5f1 (the locus which encodes Oct4), Nanog, and Sox2 themselves (left).  These transcription 
factors also occupy loci encoding lineage commitment factors (bottom), which are poised to become 
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activated upon differentiation but kept repressed in the ESCs through the action of repressive epigenetic 
regulators such as Polycomb group proteins.  Adapted from Young, 2011. 
 
The role of Sox2 in neural development 
Expression pattern of Sox2 in neural development 
 The central role Sox2 plays in the pluripotency of ESCs and the fact that Sox2 is expressed in the 
brain raised the possibility that Sox2 may regulate NPCs, the stem cells of the developing and adult 
nervous system.  Detailed analysis of the expression pattern of Sox2 further validated this hypothesis.  A 
series of β-Geo transgenes (encoding a fusion protein conferring neomycin resistance and β –
galactosidase [β-Gal] activity) driven by Sox2 regulatory elements allowed for precise identification of 
Sox2-expressing regions of the developing and adult nervous system (Zappone et al., 2000).  Using these 
tools, Sox2 was shown to mark neurogenic regions throughout development.  Sox2 expression in the 
epiblast was maintained in the ectoderm specifically and lost in the mesoderm and endoderm.  Sox2 then 
marks the neural plate at e7, and later the early neuroepithelium from e8.5 to e10.5.  By e12.5 expression 
marks to the dorsal side of the telencephalic vesicles, which are destined to become the cortex.  As this 
tissue develops, Sox2 remains high in the mitotic, undifferentiated regions near the ventricular zone, and 
is low in the higher, less mitotic and more differentiated layers.  By e17.5 Sox2 expression persists in the 
neurogenic ventricular zone, and in the adult is maintained there, in the hippocampus, and in the rostral 
migratory stream, which consists of migrating mitotic neuroblasts destined to become fully differentiated 
olfactory neurons when they reach the olfactory bulb.  Thus, Sox2 marks neurogenic regions of the 
developing and adult nervous system. 
This pattern suggested that Sox2 may mark NPCs in the brain.  To test this directly, telencephalic 
regions of e14.5 Sox2-β-Geo transgenic embryos were explanted in grown in vitro as neurospheres.  The 
neurosphere assay was one of the first experimental tests developed to measure stem cell activity in the 
developing brain (Reynolds and Weiss, 1992).  In these assays, cells are explanted and grown in 
suspension at clonal density.   Cells with stem cell properties can proliferate to give rise to spherical 
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floating colonies of cells, containing a mix of differentiated cells and stem and progenitor cells.  In this 
experiment, stem cells (as defined by the ability to give rise to neurospheres) showed both neomycin 
resistance and β-Gal activity, indicating that they expressed Sox2.  Another study using mice harboring a 
Sox2-GFP reporter transgene demonstrated that the GFP-positive fraction of cells in the embryonic brain 
contained almost all of the cells with the potential to create neurospheres (D’amour and Gage, 2003).  In 
an in vivo setting, lineage tracing analysis demonstrated that Sox2-expressing cells in the adult 
hippocampus give rise to neurons, astrocytes, oligodendrocyes, and importantly new Sox2-positive NPCs, 
demonstrating that they are indeed stem cells (Figure 3) (Suh et al., 2007).  Thus, Sox2 marks NPCs, the 
stem cells of the developing and adult central nervous system.  
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Figure 3: Sox2+ cells proliferate to give rise to differentiated neurons, glia, and new Sox2+ cells.  A. 
Experimental outline.  A lentiviral construct encoding GFP and Cre recombinase transgenes under the 
control of Sox2 regulatory elements (Sox2-GFP/CRE) was injected into the dentate gyrus of the 
hippocampus of ROSA26-lox-Stop-lox-GFP reporter mice.  Since lentiviral Cre and GFP were under the 
control of Sox2 regulatory elements, Cre-mediated recombination of the floxed Stop cassette in the 
ROSA locus occurred in Sox2 expressing cells.  Importantly, lentiviral GFP and Cre were expressed in 
Sox2+ cells only, and shown to be efficiently repressed as NPCs turned off endogenous Sox2 and 
differentiated.  Thus, GFP expression in these experiments in non-NPC cell types likely originates from 
the ROSA26 locus after Cre-mediated excision of the floxed stop cassette.  The recombination at the 
genomic level allowed lineage tracing of cells expressing Sox2 at the time of infection.  Ten or 28 days 
after virus injection, BrdU (red) was administered to label proliferating cells.  One month after BrdU 
injection, the fate of progeny was examined by staining for cell-type-specific markers and GFP. Sox2
 
expressing cells underwent cell proliferation as evidenced by BrdU incorporation and gave rise to 
neuronal precursors positive for NEUROD (B) or DCX (doublecortin) (C) and granular neurons 
expressing PROX1 (D). GFAP
+
 (E) and S-100β+ (F) glial cells were also generated from Sox2+ cells by 
mitosis. Sox2
+
 cells also gave rise to new undifferentiated cells positive for SOX2 (G) or BLBP (H) by 
mitosis. Abbreviations are the following: s, subgranular zone; g, granular layer; m, molecular layer. Scale 
bar, 10 μm.  Adapted from Suh et al., 2007. 
 
Functional role of Sox2 in NPCs  
 Sox2 is a marker of NPCs, but what functional role does it play in these cells?  To answer this 
question, genetic studies were carried out to examine the gain-of-function and loss-of-function 
phenotypes of Sox2 in the nervous system specifically.  Overexpression of Sox2 in NPCs in the 
developing chick prevented these cells from migrating into the outer layers of the neural tube and 
differentiating, indicating that exogenous Sox2 blocks exit from the progenitor state and adoption of 
differentiated identity (Graham et al., 2003; Bylund et al., 2003).  This phenomenon was later confirmed 
in mouse, where overexpression of Sox2 prevented immature Schwann cell precursors from 
differentiating into myelinating oligodendrocyes in the spinal cord, and overexpression of Sox2 in the 
developing neocortex prevented the differentiation of precursor cells into neurons (Le et al., 2005; Bani-
Yaghoub et al., 2006).  Further, expression of a Sox2 dominant negative cDNA in the developing chick 
neural tube caused precocious differentiation of NPCs in neurons (Graham et al., 2003; Bylund et al., 
2003).  This indicated that loss of Sox2 function in NPCs forced them to exit the NPC state, but was 
complicated by the existence of other Sox family members expressed in NPCs, the function of which 
could also be affected by a Sox2 dominant negative.  Taken together, these studies demonstrated that 
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Sox2 expression enforces the NPC state and suggests that Sox family function in NPCs is important for 
the maintenance of NPC identity.  
 Genetic studies in the mouse further refined our understanding of the role of Sox2 in NPCs.  In 
one such system, compound heterozygous mice harboring one Sox2 knock-out (KO) allele and one 
hypomorphic allele were generated.  These mice exhibited a wild-type Sox2 tissue expression pattern, but 
at a level 25%-30% of that of wild-type (Ferri et al., 2004).  Sox2 KO/hypomorph mice exhibited reduced 
viability beginning in late embryogenesis and pleiotropic brain defects, including cerebral malformations 
with loss of mature neural subtypes and ventricle enlargement, loss of neurones, L-Dopa-rescuable 
circling behavior, and epilepsy.  Importantly, in these mice NPC proliferation in the dentate gyrus, the 
ventricular zone, and the rostral migratory stream was dramatically decreased, and adult GFAP-
positive/Nestin-positive hippocampal neural precursor cells are strikingly diminished.  These data suggest 
that reduced expression of Sox2 results in brain malformation and compromised NPC function. 
Later, Sox2 was conditionally ablated in NPCs Cre-Lox strategies, in which mice homozygous 
for a Sox2 allele in which the coding sequence is flanked by LoxP sites are bred into a strain which 
expresses a Cre recombinase transgene under the control of regulatory element of the Nestin gene (Miyagi 
et al., 2008; Favaro et al., 2009).  Both studies demonstrated that the genesis and function of NPCs during 
neural development was affected in neurogenic regions of the developing CNS by the loss of Sox2, and 
that the maintenance of NPCs after birth was severely compromised in mutant animals.   This was 
complicated by the expression of other Sox factors in NPCs which may compensate for the loss of Sox2, 
some of which were shown to be upregulated in Sox2-null NPCs (Miyagi et al., 2008).  In a 129Ola 
background, Sox2 conditional mice did not survive longer than 12 hour post-partum (Miyagi et al., 2008).  
In a 129S1/SvI background, Sox2 conditional mice also showed high mortality and do not survive past 
four weeks (Favaro et al., 2009).  The cause of this background specific difference is not clear.  In 
129S1/SvI Sox2-null mice, at P0 there was a reduction in neurogenesis, and by P7 there was a total loss 
of GFAP-positive/Nestin-positive NPCs in the brain, no proliferation, and an increase in apoptosis.  Both 
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studies show that when cultured in vitro as neurospheres, Sox2-null NPCs have reduced proliferative and 
developmental potential. The loss-of-function phenotype of Sox2 in NPCs is similar to the loss of 
components of the Wnt and Sonic Hedgehog (Shh) signaling pathways in these cells (Machold et al., 
2003).  Interestingly, exogenous Shh or Shh chemical agonists can rescue some of the loss of Sox2 
phenotype, indicating that part of the function of Sox2 in NPCs is to regulate this pathway.  Thus, Sox2 is 
not only expressed in NPCs but is crucial for NPC maintenance and cell identity. 
The genome-wide role of Sox2 in NPCs 
 Given the critical role Sox2 plays in NPCs, attempts were made to define the genome-wide 
targets of Sox2 in these cells.  In one such study, Sox proteins were profiled from ESCs, where Sox2 is 
expressed, through NPCs which express Sox2 and Sox3, up to immature neurons which express Sox11 
(Bergsland et al., 2011).  These data confirmed that in ESCs, Sox2 occupied a set of repressed regulators 
of neural development and suggested that many of these loci became bound by Sox3 in NPCs and 
activated.  While data  presented indicating a high degree of overlap between  Sox2 and Sox3 bound 
regions in NPCs, only Sox3 targets are characterized fully in this study.  In NPCs, Sox3 was shown to 
occupy the regulatory regions of a subset of Sox2-ESC target genes involved in neural development, 
some of which were expressed in NPCs.  This indicated that in NPCs Sox3 could activate a subset of the 
loci which were poised by Sox2 in ESCs.  Finally, upon terminal differentiation some non-expressed 
Sox2-ESC/Sox3-NPC targets were passed off to Sox11 in immature neurons and activated.  Thus, Sox 
proteins seem to act as pioneer factors throughout neural development.  Left undefined by this study is the 
complete nature of Sox2 targets in NPCs, and importantly how such similar factors can have varying 
effects on targets depending on the cellular context.  Another study compared Sox2 targets genome-wide 
in NPCs to the ATP-dependent chromatin remodeler Chd7 (Engelen et al., 2011).  These factors 
overlapped extensively, and co-occupied many targets which are disregulated in CHARGE syndrome, 
which is known to be caused by haplo-insufficiency of Chd7.  Interestingly, CHARGE syndrome shares 
many clinical features with a disease associated with loss of Sox2 function, Anophthalmia (see below 
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“Sox2 in Diseased States”).  It was not clear from this study whether the interaction with a chromatin 
remodeler such as Chd7 could stabilize Sox2 on DNA targets in the same way a sequence specific 
transcription factor like Oct4 does in ESCs, so how Sox2 can bind to NPC-specific targets without 
complexing with a transcription factor such as Oct4 was not addressed.  These studies have added to our 
understanding of the function of Sox2 in NPCs, but left many questions unanswered. 
Sox2 in other Tissues 
Sox2 marks stem/progenitor cells in non-neural lineages and functions to regulate stem/progenitor 
identity 
 Sox2 is expressed in tissues other than ESCs and NPCs, and many of these cells also display 
stem/progenitor cell characteristics.   During development and in the adult, Sox2 marks cells in various 
tissues, including the lens, testes, lung, trachea, stomach, embryonic foregut, inner ear, taste bud, the 
stomach and many regions of the gastrointestinal tract, cervix, and thymus (Kamachi 1995; Cimpean et 
al., 2001; Mansukhani et al., 2005; Kiernan et al., 2005; Okubo et al., 2006; Gontan et al., 2008; Domyan 
et al., 2011; Arnold et al., 2011).  In stem/progenitor cells of the testes, lung, trachea, taste bud, lens, and 
in osteoblasts, loss-of-function of Sox2 leads to a decrease in proliferation, loss of stem/progenitor cell 
markers, and disruption tissue homeostasis, demonstrating that Sox2 is important for stem cell identity in 
these contexts, similar to its role in ESCs and NPCs (Okubo et al., 2006; Que et al., 2009; Tompkins et 
al., 2009; Basu-Roy et al., 2011; Holmes et al., 2011; Arnold et al., 2011).  Lineage tracing has confirmed 
that in the testes, glandular stomach, and in the lens, Sox2-positive cells give rise to differentiated cells 
(Arnold et al., 2011).  For example, in the glandular stomach, Sox2-expressing cells give rise to 
enteroendocrine cells, mucus cells, and parietal cells, indicating that they are multipotent, and in the testes 
Sox2-positive spermatogonial stem cells can entirely reconstitute spermatogenesis when transplanted into 
infertile male mouse testes (Arnold et al., 2011).  Thus, Sox2 is a marker of stem cells in multiple tissues. 
Sox2 in diseased states 
 Given the potent effect of Sox2 on development, it is perhaps not surprising that dysfunction of 
Sox2 can lead to disease in humans.  Mutations in Sox2 have been linked to the ocular malformation 
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disease Anophthalmia, and more broadly to Anophthalmia-Esophageal-Genital (AEG) syndrome, in 
which patients exhibit developmental defects in the eye, esophagus, and genital region (Fantes et al., 
2003; Guichet et al., 2004; Hagstrom et al., 2005; Ragge et al., 2005; Williamson et al., 2006).  Some 
patients with mutations in Sox2 also exhibit deafness (Hagstrom et al., 2005).  Interestingly, Sox2 has 
been shown to play a role in the development of the eye, esophagus, testes, and inner ear tissues in the 
mouse (above).  Sox2 has also been shown to mark many cancers in tissues in which Sox2 normally plays 
a role in stemness, including glioblastoma in the brain, stomach adenocarcinoma, lung and esophageal 
squamous cell carcinoma, thymoma, osteosarcoma and others (Vural et al., 2008; Bass et al., 2009; 
Cimpean et al., 2001; Basu-Roy et al., 2011; Fang et al., 2011), suggesting that these cancers might co-
opt endogenous stem cell-like programs during oncogenesis in these tissues.  Thus, the high potency of 
Sox2 in developmental fate transitions is reflected in the human diseases manifested when Sox2 
expression is abnormal.   
Brn1 and Brn2 are CNS Specific POU Factors Which May Partner with Sox2 
Brn1 and Brn2 are part of the POU-homeobox family 
The POU-homeobox family was first defined in 1988, when many labs pointed out the high 
degree of homology in the DNA binding domains between the pituitary expressed gene mapping to the 
dwarf  locus in mouse, Pit-1, the mouse Octamer binding transcription factors Oct1 and Oct2, and the 
CNS expressed C. elegans gene Unc-86 (Herr et al., 1988).  POU factors all contain a bi-partite DNA 
binding domain consisting of a POU homeodomain (POUH) and a POU specific domain (POUS), 
separated by an flexible linker (Ryan and Rosenfeld, 1997).   These linkers are highly variable between 
POU factors, but highly conserved within sub-classes, even across species (Treacy and Rosenfeld, 1992).  
Outside the POU domain, there is little conservation between POU factors, but some amino-acid rich 
motifs are shared within subclasses, such as the presence of Glutamine-rich repeats in class III POU 
factors (which includes Brn1 and Brn2) (Treacy and Rosenfeld, 1992).  Like Oct1 and Oct2, they all bind 
a variant of the canonical Octamer motif 5’-ATGCAAAT-3’, originally discovered to drive expression of 
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immunoglobulin genes in the lymphoid lineage and be bound by a ubiquitously expressed factor (Oct1), 
and a lymphoid specific factor (Oct2) (Mason et al., 1985; Wirth et al., 1987; Wang et al., 1987; Staudt et 
al., 1988; LeBowitz et al., 1988).  Using a degenerate PCR approach searching for cDNAs with homology 
to the POU domain, Brn1 and Brn2 were cloned, and probes from these cDNAs were used to show that 
Brn1 and Brn2 were widely expressed in the developing and adult rat nervous system in an almost 
completely overlapping way (He et al., 1989).  Notably, Brn1 was detected in the rat kidney while Brn2 
was absent in this organ.  The overlapping expression pattern on the cellular level of Brn1 and Brn2 and 
the high homology in their DNA binding domain indicates that they may be able to regulate the same 
genomic targets in vivo (Treacy and Rosenfeld, 1992).  Soon the mouse Brn1 and Brn2 homologs were 
cloned from the developing mouse brain, indicating their expression pattern is conserved (Hara et al., 
1992).  Many other POU factors were discovered in this way until the family was found to consist of 
seven subfamilies, Groups I-VII, and encompass more than 150 POU-domain containing proteins across 
species including at least 14 in mouse (Phillips and Luisi, 2000).  Brn1 and Brn2 fall into POU group III, 
and are designated Pou3f3 (POU group III, factor three) and Pou3f2 (POU group III, factor two), 
respectively.  Thus, like Sox2, Brn1 and Brn2 belong to a large and highly conserved family of 
transcription factors. 
Loss-of-function of Brn1 and Brn2 causes pleiotropic brain defects 
 Knock-out (KO) of Brn1 and Brn2 resulted in dysfunction of NPCs and subsequent malformation 
of specific brain regions.  Brn2 KO animals were not viable, exhibiting lethality between P0 and P10 
(Nakai et al., 1995).  They exhibited a hypoplastic pituitary gland which led to a small body size and a 
decrease in body fat.  In the brain, specific neuronal subtypes (mangocellular neurons of the 
paraventricular nuclei and the supraoptic nuclei of the hypothalamus) are totally absent, due to death of 
NPCs at e12.5 which are destined to give rise to these cell types.  Brn1 KO animals also die shortly after 
birth, probably due to renal failure (Nakai et al., 2003), but also exhibit multiple brain defects including a 
malformed hippocampus due to a failure of NPCs to properly migrate to the outer layers of this tissue 
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(McEvilly et al., 2002).  Interestingly, expression of Brn1 was increased 30% at the protein level in 
homozygous Brn2 knockout animals, thus it is possible that the upregulation of Brn1 in Brn2 KO animals 
was compensating for the loss of Brn2 and masking the true role of this factor.  Further, detailed analysis 
of Brn1 and Brn2 expression revealed that only Brn1 was detected in the CA1 region of the hippocampus.  
Brn2 was not upregulated in hippocampus of Brn1 KO animals, possibly explaining why this region was 
specifically affected by loss of Brn1.  To address the question of compensation Brn1/Brn2 double knock-
out (DKO) mice were generated.  In Brn1/Brn2 DKO animals, regions affected in each single KO were 
similarly malformed, but new brain regions not known to be affected in either single KO were also 
affected, such as the cerebral cortex and specifically the neocortex (McEvilly et al., 2002; Sugitani et al., 
2002).  In this region, NPCs in the subventricular zone at e13.5 and beyond were non-proliferative and 
failed to migrate to the outer layers of the cortex.  This defect was shown to be cell autonomous, as other 
cells in the region which guide NPC migration neither expressed Brn1/Brn2 nor were affected by their 
loss.  Thus, Brn1 and Brn2 have both distinct and overlapping roles in the developing brain, specifically 
in hypothalamic, hippocampal, and cortical NPCs. 
Brn1 and Brn2 function with Sox2 at NPC specific target loci 
Brn1 and Brn2 therefore seemed to play roles in the development of the brain similar to that of 
Sox2.  Interestingly, known target loci of Brn1 and Brn2 were shown to be shared with Sox2, indicating 
that they may constitute a new Sox:POU module regulating development.  The Nestin Nes30 enhancer 
lies within the first intron of the Nestin locus and is conserved in mouse, rat, and human.  This enhancer 
contains Sox and POU binding sites in close proximity to one another, and these sites must maintain 
correct orientation in respect to one another for proper enhancer activity (Tanaka et al., 2004).  In vitro, 
Sox2 and Brn2 were able to synergistically drive expression from a reporter construct regulated by this 
sequence, but not if the spacing or orientation of the Sox and Octamer site is altered.  Another important 
enhancer in the developing nervous system is SRR1, a 5’ regulatory element of Sox2 which drives Sox2 
expression in the neural lineage.  Electrophoretic mobility shift experiments demonstrated that two 
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protein:DNA complexes formed on this element when it was incubated with mouse brain lysates; one 
Brn1 dependent, another Brn2 dependent (Catena et al., 2004), indicating that this element may be bound 
and regulated by Brn1 and Brn2 in the mouse brain.  Direct evidence of Brn1 and Brn2 regulation of Sox2 
in vivo was provided when chromatin immunoprecipitation assays from the forebrain of adult mice 
showed that Brn1, Brn2 and Sox2 occupied a 3’ regulatory region of Sox2, SRR2 (Miyagi et al., 2006).  
Recently, in an analogous fashion to the role of Sox2 and Oct4 in factor mediated reprogramming, ectopic 
expression of Sox2 and Brn2 with the forkhead factor FoxG1 was shown to transdifferentiate fibroblast 
cells into neural precursor-like cells, which could differentiate and self-renew (Lujan et al., 2012).  
Therefore, part of the function of Sox2 and the Brn factors may be to regulate gene expression programs 
in NPCs in a combinatorial way to ensure proper execution of CNS development. 
Summary 
Sox2 is a master regulator of both pluripotent ESCs and multipotent NPCs.  These cell types share certain 
characteristics, such as high developmental potency and self-renewal, but are molecularly and 
phenotypically distinct.  The major question of this thesis will be how Sox2 can regulate these two 
distinct identities.  Part of the answer lies with the partnership between Sox2 and cell-type-specific POU 
factors; the partnership between Sox2 and Oct4 in ESCs is well characterized, and the interaction between 
Sox2 and the CNS specific POU factors Brn1 and Brn2 is an emerging Sox:POU module which may 
prove important for NPC biology.  Advances in genome-wide analytic technologies have elucidated the 
pervasiveness of distal enhancers in transcriptional control, and while Sox2 and Oct4 have been shown to 
bind a multitude of enhancers in ESCs, the global regulation of these elements in NPCs by Sox2, Brn1 
and Brn2 is only recently becoming clear.  Data presented in the following chapters will resolve key 
questions regarding the role of Sox2 and its POU factor partners in controlling transcription and 
developmental transitions. 
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Chapter Synopsis 
Sox2 is a master regulator of several stem cell compartments, including pluripotent embryonic 
stem cells (ESCs) and multipotent neuronal progenitor cells (NPCs), yet how Sox2 controls distinct stem 
cell identities is not fully understood.  Here we show by genome-wide analysis that while Sox2 occupied 
promoter regions in ESCs and NPCs with cell-type-specific functions, the majority of Sox2-bound 
regions mapped to a distinct set of distal enhancer elements linked to loci encoding developmental 
regulators.  Notably, we found that Sox2 co-occupied a large subset of enhancers with the central-
nervous-system expressed POU factors Brn1 and Brn2 in NPCs, similarly to its interaction with the POU 
family member Oct4 in ESCs.  Consistent with a role in neural specification, forced expression of Brn2 in 
ESCs leads to up-regulation of neural markers and premature differentiation.  Further analysis revealed 
that Sox2:Brn1 and Sox2:Brn2 sites were distinguished by a SOX-POU composite motif in a distinct 
configuration compared to Sox2:Oct4 regions, suggesting that particular Sox2-POU combinations bind 
DNA in different conformations. As Sox2 is a key factor in lineage specification, somatic cell 
reprogramming, and direct transdifferentiation, our findings have important implications for 
understanding these processes. 
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M.A.L., L.A.B., and R.J. conceived experiments and interpreted data.   M.A.L. and A.W.C. analyzed 
microarray data.  M.A.L and C.N. performed motif spacing and peak distribution analyses.  M.A.L and 
J.A.W. edited figures  M.A.L. and K.T. performed Sox2 ESC ChIP.  M.A.L performed all other 
experiments and analyzed data.  M.A.L. and L.A.B. wrote the chapter. 
 
48 
 
Introduction 
Transcription factors bind to DNA in a sequence-specific manner and regulate which genes in the 
genome will be expressed in a given cell type, and thus are thought to sit at the top of a hierarchy 
controlling cellular identity.   In embryonic stem cells (ESCs), master regulatory transcription factors, 
such as the HMG-box-containing factor Sox2, control both the ESC cell state and set the stage for later 
developmental transitions.  Given this crucial role, it is not surprising that Sox2 is essential for the 
development of a functional inner cell mass (ICM) in the mammalian embryo (Avillion et al., 2003) and 
for maintenance of ESCs in vitro (Miyagi et al., 2006).  Sox2 is also necessary for the proper function of 
neural precursor cells (NPCs) in the developing nervous system and functions in multiple adult stem cell 
populations in the gastrointestinal tract, the respiratory tract, the testes, and many other tissues (Collignon 
et al., 1996; Kamachi 1995; Cimpean et al., 2001; Mansukhani et al., 2005; Kiernan et al., 2005; Okubo et 
al., 2006; Gontan et al., 2008; Domyan et al., 2011; Arnold et al., 2011).  Thus, Sox2 is a critical regulator 
of distinct stem cell states, but how it can serve this multi-functional role is not fully understood. 
In ESCs, Sox2 is part of the core transcriptional regulatory network that controls pluripotency and 
self-renewal. Together with Oct4 and Nanog, Sox2 binds to the proximal promoter regions of many genes 
with known roles in pluripotency (including the promoters of Oct4, Sox2, and Nanog), as well as 
developmental regulators that are not expressed in ESCs but maintain the potential for activation upon 
differentiation (Boyer et al., 2005; Loh et al., 2006; Marson et al., 2008; Chen et al., 2008). These data 
suggested that Sox2 regulates pluripotency in ESCs by actively promoting pluripotency and by marking 
the regulatory regions of developmental genes for future activation.  A powerful demonstration of the 
importance of Sox2 in specifying the ESC identity is the role it plays in factor mediated reprogramming, 
by which differentiated adult cells are converted into an pluripotent state by the exogenous expression of 
three to four transcription factors, critically including Oct4 and Sox2 (Takahashi et al., 2006, Wernig et 
al., 2007; Takahashi et al., 2007).  
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In the central nervous system, Sox2 regulates development by controlling cell identity in NPCs.  
Sox2 expression marks NPCs, proliferating cells which have the ability to self-renew and differentiate 
into multiple neural lineages, in the developing and adult brain (D’Amour and Gage, 2003; Ferri et al., 
200; Suh et al., 2007). Consistent with this, Sox2 loss-of-function in the developing central nervous 
system leads to multiple brain defects, including precocious progenitor differentiation, premature lethality 
and a reduced proliferating cell population in the brain (Graham et al., 2003; Bylund et al., 2003; Miyagi 
et al., 2008, Favaro et al., 2009). Furthermore, forced expression of Sox2 has been shown to block 
terminal differentiation of NPCs (Graham et al., 2003; Bylund et al., 2003; Le et al., 2005; Bani-
Yaghoub, 2006).  Thus, Sox2 is necessary and sufficient for maintenance of the stem cell state of NPCs in 
the brain.   
While the genetic role of Sox2 in the pregastrulation embryo and in the development of the CNS 
at midgestation is well understood, the molecular mechanisms by which Sox2 can regulate global gene 
expression networks in a context-specific manner is only recently becoming clear, and much remains to 
be learned.  In ESCs, Sox2 regulates active genes but also functions as a pioneer factor at repressed 
developmental regulators, facilitating a transcriptionally competent at these loci.  For example, in ESCs 
Sox2 and FoxD3 were shown to co-occupy a B-cell specific enhancer of the λ5-VpreB1 locus and 
maintain this element as inactive until commitment to the B-cell lineage, where Sox2 and FoxD3 were 
replaced by Sox4 and expression of the locus was activated (Liber et al., 2010).  Further, many enhancers 
linked to genes involved in neural development and bound by Sox2 in ESCs were recently shown to be 
bound by other Sox family members, namely Sox3 and Sox11, as development progressed from 
pluripotent ESCs through multipotent NPCs (Sox3) and finally to immature neurons (Sox11) (Bergsland 
et al., 2011).  Notably, a large overlap was observed between Sox2 and Sox3 bound regions in this 
dataset, but a direct comparison of Sox2 target loci in ESCs and NPCs was not reported.  Thus, one facet 
of Sox2 function genome-wide seems to be the priming of distal enhancers for activation later in 
development by other Sox factors.  This is a very critical role, as recently it has become apparent that 
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distal enhancers are regulated in a more dynamic way than proximal promoters over developmental time, 
and thus may play a larger role than promoter regions in dictating cellular identity.  For example, 
monomethylation of Lysine 4 of Histone H3 (H3K4me1) and acetylation of Lysine 27 of Histone H3 
(H3K27Ac) are two chromatin marks associated with distal enhancers, and the genome-wide deposition 
of these marks varies more between cell types than that of trimethylation of Lysine 4 of Histone H3 
(H3K4me3), which is known to mark transcriptional start sites (Heintzman et al., 2007, 2009; Creyghton 
et al., 2010; Rada-Iglesias et al., 2011).  Thus, the regulation of these elements by pioneer transcription 
factors such as Sox2 may set the stage for all subsequent developmental decisions. While previous 
genome-wide studies regarding Sox2 target regions have contributed to our understanding of Sox2 
function by revealing a subset of binding sites in the two cell types, it is likely that transcription factors 
that cooperate with Sox2 in a context dependent manner will also influence its function during lineage 
commitment.  These factors may mediate target selection by Sox2 in a given cellular context, or they may 
modulate the readout of Sox2 binding by the transcriptional apparatus.  Thus, functional interactions with 
cell-type specific partner factors may be a critical determinant of Sox2 function across development. 
These functional interactions between transcription factors are critical for developmental 
decisions, yet we lack a clear understanding of the underlying molecular mechanisms controlling these 
interactions.  Sox family members are thought to weakly bind DNA and to cooperate with partner factors 
to stabilize interactions on genomic targets (Kamachi et al., 2000; Wegner et al., 2010). Interactions 
between members of the POU and Sox transcription factor families have been highly conserved during 
evolution and are important for specifying gene expression programs during early embryonic 
development in metazoans (Daily and Basilico 2001).  In ESCs, Sox2 and Oct4 have been shown to 
cooperatively bind DNA targets in distinct conformations to form stable ternary complexes (Yuan et al., 
1995; Nishimoto et al., 1999; Remenyi et al, 2003).  These distinct binding conformations have been 
suggested to confer functional specificity to Sox:POU binding by providing allosterically diverse 
interfaces for interactions with downstream effectors. While the Sox2:Oct4 partnership in ESCs is well 
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characterized, the transcription factors which partner with Sox2 at the genomic level in NPCs are not 
known.  Recently, Sox2 has been shown to co-occupy target regions with the ATP-dependent chromatin 
remodeler Chd7 in NPCs (Engelen et al., 2011), but it is not known whether an interaction with a 
chromatin modifier such as Chd7 could stabilize ternary complex formation between it, Sox2, and a DNA 
target in the same way transcription factors such as Oct4 have been shown to do.  Thus, elucidating 
transcription factors that specifically co-operate with Sox2 in ESCs and NPCs will be key to 
understanding how Sox2 can function to specify these distinct stem cell states. 
Here we show that Sox2 occupied a distinct set of promoter regions in ESCs and NPCs encoding 
both lineage regulators and more widely expressed metabolic genes.  However, the majority of enriched 
regions map to distal enhancers. We noted a very limited overlap in Sox2 occupied regions; the vast 
majority of Sox2 target regions were cell-type specific.  We confirmed that Oct4 occupied most Sox2 
regions in ESCs and found that Sox2 and the POU transcription factors Brn1 and Brn2 co-occupied many 
distal enhancers in NPCs.  These POU factors are co-expressed with Sox2 in neurogenic regions of the 
brain, and loss-of-function of Brn1 or Brn2 causes pleiotropic brain defects, including defects in NPC 
function (He et al., 1989; Hara et al., 1992; Nakai et al., 1995; McEvilly et al., 2002; Sugitani et al., 
2002).  Our data provide evidence that Sox2 binding at enhancers can dictate lineage-specific gene 
expression programs, in part, by partnering with tissue-specific POU factors. Consistent with this, forced 
expression of Brn2 in differentiating ESCs promotes their commitment towards the neural fate.  Further 
analysis revealed that Sox2:Brn1 and Sox2:Brn2 targets harbor a distinct set of Sox:POU composite 
motifs compared to Sox2:Oct4 targets. Together, these data reveal new insights into how Sox2 can 
function in a context-dependent manner to specify distinct stem cell populations during development.  
Results 
Sox2 occupies distinct regions in ESCs and NPCs 
Sox2 is a master regulator of pluripotent ESCs and multipotent NPCs, yet how the same 
transcription factor can specify these distinct stem cell states in a context specific fashion has not been 
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clear.  We reasoned that detailed analysis of Sox2 genomic binding patterns and sequence context might 
reveal how Sox2 can regulate distinct gene expression programs in ESCs and NPCs.  To this end, we 
differentiated ESCs toward NPCs using established protocols (Okabe et al., 1996), and then interrogated 
Sox2 binding sites in each cell type by chromatin immunoprecipitation followed by massively parallel 
sequencing (ChIP-Seq). ChIP-Seq analysis on Sox2 in ESCs and NPCs identified 13,717 and 16,685 
enriched regions, respectively (Methods). Biological replicates displayed high concordance and our 
results are consistent with prior data sets (Marson et al., 2008) (Figure S1) indicating that we have 
generated high quality data sets. 
We assigned Sox2 ChIP-enriched regions to genomic features to identify bound gene promoters 
and regulatory elements in ESCs and NPCs.  We identified over 29,000 Sox2-enriched regions at high 
confidence between both cell types and found that while a subset of these regions mapped to TSSs, the 
majority mapped to intragenic and intergenic regions (Figure 1a).  Notably, we find that Sox2 occupied a 
largely non-overlapping set of targets in ESCs and NPCs; using a stringent threshold >95% of Sox2 
targets are bound uniquely in one cell type or another (1,274 of the 29,129 union regions common to both 
datasets) (Figure 1b).  For example, Sox2 was associated with the Nanog promoter in ESCs but absent 
from this locus in NPCs (Figure 1c), while Sox2 was bound to the locus encoding the Notch ligand Dll1 
in NPCs but not in ESCs (Figure 1d).  Importantly, Nanog and Dll1 are critical regulators of the ESC and 
NPC state, respectively (Mitsui et al., 2003; Chambers et al., 2003; Rocha et al., 2009; Ramos et al., 
2010).  Like Nanog and Dll1, as a group genes bound by Sox2 tend to be highly expressed (Figures 1e, 
1g).  In ESCs Sox2 promoter targets code for epigenetic and other transcriptional regulators, including 
core histone genes (Figure 1f).   In NPCs Sox2 also occupied the promoters epigenetic and transcriptional 
regulators, but also genes involved in other cellular metabolic functions such as the regulation of the 
Ubiquitin cycle and regulation of translation (Figure 1h, not shown).  A large group of these genes encode 
factors involved in RNA processing, specifically regulators of RNA splicing (Figure 1h).  While splicing 
is also a general cellular function, alternative splicing is known to play a key role in the development of 
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the brain (Grabowski, 2011), and many factors involved in alternative splicing are Sox2 target in NPCs.  
Thus, Sox2 is bound to distinct sets of active promoters involved in cell identity in both cell types. 
The fact that the majority of Sox2 binding in the genome occurred distal to promoters indicated 
that Sox2 may be controlling larger network of genes than those it bound near the TSS.  Recently, much 
attention has been on distal enhancers and the role these elements play in controlling gene expression.  
Work from our lab and others has shown that distal enhancers are enriched for nucleosomes marked by 
monomethylation on Lysine 4 of Histone H3 (H3K4me1) and/or acetylation of Lysine 27 on Histone H3 
(H3K27Ac) (Heintzman et al., 2007, 2009; Creyghton et al., 2010; Rada-Iglesias et al., 2011).  These 
marks are distributed in the genome is a highly cell type specific manner, and genes closest these marked 
regions are highly expressed.  In order to ascertain whether Sox2 binds near these elements, we surveyed 
1 kb up and downstream of peaks of H3K4me1 and H3K27Ac enrichment for Sox2-bound regions in 
ESCs and NPCs.  Indeed, we find that many Sox2-enriched regions that could not be assigned to 
promoters were highly correlated with enhancer chromatin marks in both ESCs and NPCs.    Further, we 
find that Sox2 binds to more regions modified with H3K4me1 and/or H3K27Ac than annotated start sites 
(Figure 1i).  Thus Sox2 occupied two distinct sets of active promoters and distal enhancers in ESCs and 
NPCs. 
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Figure 1 - Sox2 targets distinct sets of promoters and enhancers in ESCs and NPCs. (a) Location 
analysis breakdown of Sox2 peaks relative to annotated transcriptional start sites. Numbers on pie chart 
indicate fraction of bound regions which fall into each category. (b) Heat maps of Sox2 enrichment in 
ESCs and NPCs centered on peaks of enrichment and extended 4kb in each direction. (c,d) Gene plots 
showing Sox2 density at Nanog and Dll1 in ESCs (left, blue) and in NPCs (right, red). y-axis corresponds 
to reads per million.  Scale bar corresponds to 1 kb.  Genomic positions reflect NCBI Mouse Genome 
Build 36 (mm8).  (e, g)  Box and Violin plots representing expression data from Affymetrix arrays of 
genes linked to Sox2 target TSSs. y-axis corresponds to percentile expression rank, * = p-value < 0.01, 
Student’s T-test.  (f,h) Gene ontology analysis of genes linked to Sox2 target TSSs.  (i) Fraction of total 
start sites or total marked enhancers associated with Sox2 enriched region within 1 kb in ESCs and NPCs.  
Numbers above bars reflect absolute numbers of bound regions and genomic features. 
 
Brn1 and Brn2 co-occupy enhancer regions with Sox2 in NPCs 
Our observation that Sox2 bound to distinct sets of target loci in ESCs and NPCs suggests that 
Sox2 may utilize a distinct mechanism to bind to genomic targets in these cells.  We performed an 
unbiased motif analysis of Sox2 targets and identified sequences highly similar to the canonical motif for 
Sox2 binding, 5’-CTTTGTT-3’ (Yuan et al., 1995; Collignon et al., 1996, Kamachi et al., 1999; Salmon-
Divon M. et al., 2010), enriched in ESC and NPC Sox2 targets, indicating that Sox2 uses the same DNA 
recognition sequence to bind targets in both cells (Figure 2a). This suggested that Sox2 may collaborate 
with other cellular factors to recognize tissue-specific genomic targets. 
While Sox2 functions with the POU-domain-containing transcription factor Oct4 in ESCs, Oct4 
is not expressed in NPCs.  In order to define a set of possible partner factors for Sox2 in NPCs, we 
analyzed transcription factor binding motifs near peaks of Sox2 enrichment in in these cells.  We 
determined enrichment of all annotated transcription factor binding motifs in the TRANSFAC database 
and found recognition motifs for many transcription factors to be enriched.  Notably, we identified a motif 
recognized by the POU factor Brn2 as highly enriched (Figure 2b).  The presence of this motif caught our 
attention for several reasons.  First, the interaction between Sox and POU factors is a conserved 
partnership in all metazoans (Dailey and Basilico, 2001).  Second, our transcriptome data analysis 
identified Brn2 (encoded by Pou3f2) and its paralog Brn1 (encoded by Pou3f3) as POU factors that were 
highly expressed in NPCs but not in ESCs (Figure S2).  Third, Brn2 and Brn1 are co-expressed with Sox2 
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in NPCs and loss-of-function of these factors is detrimental to NPC function (He et al., 1989; Hara et al., 
1992; McEvilly et al., 2002; Sugitani et al., 2002).  Additionally, the combination of Sox2, Brn2, and the 
forkhead transcription factor FoxG1 has been shown to enforce a NPC-like state on fibroblast cells, 
indicating that Sox2 and Brn2 may combinatorially control NPC identity in an analogous fashion to Sox2 
and Oct4 in ESCs (Lujan et al., 2012).  Therefore, we hypothesized that Brn1 and Brn2 could function as 
Sox2 partner factors in NPCs. 
We performed ChIP-Seq to test whether Brn1 and Brn2 bound to a similar set of genomic regions 
as Sox2 in NPCs. Our analysis identified 8,867 and 6,574 enriched regions for Brn1 and Brn2, 
respectively. We observed that Oct4 and the Brn factors target distinct regions of the genome in ESCs and 
NPCs and that those bound by Brn1 and Brn2 in NPCs are highly correlated (Figure 2c).  Brn1 and Brn2 
sites, like Oct4 bound regions, were enriched for a sequence highly similar to a canonical octamer motif 
5’-ATGCA/T A/T A/T A/T -3’ (Staudt et al., 1996; Phillips and Luisi, 2000) (Figure S3). The high 
correlation between Brn1- and Brn2-bound genomic regions is consistent with the homology in their 
DNA binding domains (Treacy and Rosenfeld, 1992), motif preference, ability to compensate for each 
other in knockout experiments (McEvilly et al., 2002; Sugitani et al., 2002), and known individual targets 
known to be bound by both Brn1 and Brn2 in vivo (Catena et al., 2004; Tanaka et al., 2004).  
Interestingly, like Sox2, Brn1 and Brn2 bind to more enhancer regions than promoters (Figure S3).  Oct4 
is known to regulate genes involved in pluripotency and lineage commitment, whereas Brn1 and Brn2 
occupied enhancers appear to reside near genes with roles in NPC identity and differentiation into 
neurons and glia (Figure S3).  Thus, Brn1 and Brn2 occupy many genomic regions by utilizing a 
canonical Octamer motif in NPCs, and these regions are distinct from those bound by Oct4 in ESCs. 
We then examined the overlap between the POU factors and Sox2 in ESCs and NPCs.  We 
confirmed that Sox2 and Oct4 showed significant overlap at promoters and enhancer regions in ESCs 
(Figure S4) (Boyer et al., 2005; Loh et al., 2006; Marson et al., 2008; Chen et al., 2008). In contrast, 
binding of Sox2 and Brn1 and Brn2 overlapped predominantly at distal enhancer regions (Figure 2d; 
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Figure S4) but was not present at many Sox2 target promoters.  For example, Sox2, Brn1, and Brn2 were 
bound at putative enhancers 5’, 3’, and within and intron of the Notch1 locus, while only Sox2 was 
present the Notch1 TSS.  Also, Sox2, Brn1, and Brn2 co-localized 3’ of the Ascl1 locus, while Sox2 was 
bound to the promoter of this gene without Brn1 or Brn2 (Figure 2e).  Thus, Sox2, Brn1, and Brn2 
predominantly co-occupied enhancer regions in NPCs, unlike Sox2 and Oct4 in ESCs which showed 
extensive co-localization at promoters as well.   
We next sought to define the functional role Sox2, Brn1, and Brn2 may have in binding enhancer 
regions in NPCs.  These factors bound more H3K4me1+/H3K27Ac-, or poised, enhancers than 
H3K4me1+ /H3K27Ac+ or H3K4me1-/H3K27Ac+, active elements (Figure 2f).  Genes linked to 
Sox2:Brn1 and Sox2:Brn2 bound active enhancers were expressed at a higher level than those genes 
linked to poised elements (Figure 2g).  Gene ontology analysis revealed that genes associated with Sox2, 
Brn1, and Brn2 bound enhancers in NPCs are involved in early nervous system development, particularly 
in neurogenesis (Figures 2h, 2i).  Genes linked to active enhancers included transcription factors known 
to play a role in NPC identity such as Sox2 and Notch1, components of cell signaling cascades which 
support NPC function such as the Trk and EGF pathways (Xian and Zhou, 2004; Bartkowska et al., 
2007), and genes involved in cell migration and cell adhesion, the balance of which plays a pivotal role in 
shaping the developing CNS (Morest and Silver, 2003).  Interestingly, genes linked to poised enhancers 
are specifically enriched for regulators of later neuronal developmental stages, such as the proneural 
transcription factor Math1, genes involved in axon guidance, and genes involved in signaling pathways 
which are crucial for neuronal development, such as the L1CAM, Nectin, and Wnt (Haney et al., 1999; 
Fradkin et  al., 2005; Park et al., 2008), supporting the notion that Sox2 may act as a pioneer factor to set 
the stage for further development of NPCs and suggesting Brn1 and Brn2 may also be in this class of 
genes.  Taken together, these data demonstrate an enhancer-specific, genome-wide Sox:POU interaction 
in NPCs may be critical for both stem cell maintenance and fate commitment. 
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Figure 2 - Sox2 co-localizes with Brn1 and Brn2 at enhancer regions of genes involved in neural 
development in NPCs. (a) Motifs similar to the canonical Sox2 motif enriched by MEME motif analysis 
of Sox2 bound regions in ESCs and NPCs (b) Brn2 motif enriched in Sox2 target regions in NPCs.  (c) 
Correlation matrix comparing Oct4, Brn1, and Brn2 enriched regions in ESCs and NPCs.  (d) Heat maps 
of Sox2, Brn1, and Brn2 enrichment in NPCs centered on peaks of enrichment and extended 4kb in each 
direction at TSS regions and marked enhancer regions. (e) Gene plots showing density of indicated ChIP-
Seq datasets at indicated loci.  y-axis corresponds to reads per million. (f) Breakdown of number of 
Sox2:Brn1 and Sox2:Brn2 target enhancers are H3K4me1+, H3K27Ac- (poised) or H3K4me1+/-, 
H3K27Ac+ (active).  (g) Expression level of genes linked to poised and active Sox:POU target enhancers 
in NPCs.  (h) Gene ontology analysis of genes linked to poised and active Sox:POU target enhancers in 
NPCs. 
 
Different Sox2:POU combinations display a distinct binding site configurations  
While Sox2 and the POU factors seem to use highly similar Sox and Octamer motifs to bind 
genomic targets in ESCs and NPCs, the loci these factors actually bind are almost mutually exclusive.  
We therefore sought to refine our understanding of how Sox2, Oct4, Brn1 and Brn2 find genomic targets 
in ESCs and NPCs.  First, we searched Sox2:Oct4, Sox2:Brn1, and Sox2:Brn2 bound regions for other 
conserved transcription factor binding sites.  Indeed, we found that Sox2:Oct4 co-occupied regions also 
contained a set of binding sites for other transcription factors, and this set was distinct from those which 
associate with Sox2:Brn1 and Sox2:Brn2 (Figure S5).  Interestingly, the recognition sites for other known 
regulators of neurogenesis which are expressed in NPCs, such as Rfx factors and NF-I, were enriched in 
Sox2:Brn1 and Sox2:Brn2 bound regions (Figure S5).  These data indicate that Sox2, Brn1, and Brn2 
might partner with these other factors to regulate transcription in NPCs, and raises the possibility that the 
interaction with distinct sets of partner factors in ESCs and NPCs may in part guide Sox2:POU target 
selection. 
Previous studies have indicated that the relative position of Sox and Octamer motifs to each other 
could affect the ability of Sox and POU factors to utilize these composite motifs.  Sox2 and Oct4 are 
known to bind in very close proximity to each other to a composite Sox:POU motif consisting of a 5’ Sox 
site, a 1  bp spacer, then a 3’ Octamer site at many targets in ESCs.  Some variants of this motif 
orientation can also be bound by Sox2 and Oct4, while others cannot (Ambrosetti et al., 1997; Remenyi et 
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al., 2003).  Further, different motif conformations have different effects on the ability of binding to induce 
transcription (Botquin et al., 1998).  This sensitivity to orientation extends to other pairings of Sox and 
POU family members (Kuhlbrodt et al., 1998; Tomoika et al., 2002; Tanaka et al., 2004; Reiprich et al., 
2010).  Thus, we sought to define the motif preferences for Sox2:Brn1 and Sox2:Brn2 in NPCs to 
possibly explain how these modules can regulate global gene expression networks in a distinct way from 
Sox2:Oct4.   
In some cases, it seems Sox2:Oct4, Sox2:Brn1, and Sox2:Brn2 can bind to a given site in the 
genome, but have different effect on transcription.  For example, an intronic enhancer of the Nestin locus 
contains a Sox:Pou composite motif comprised or a 5’ Octamer site followed by a 7-bp spacer and then an 
Sox site (Tanaka et al., 2004).  Reversing the orientation of these motifs to one similar to the known 5’ 
Sox, 3’Octamer pattern in Sox2:Oct4 targets rendered it unable to be activated by Sox2:Brn2, which 
drives activity of this element in the brain.  This site can be bound by Sox2:Oct4, Sox2:Brn1, and 
Sox2:Brn2 in vitro, and this binding can drive expression of a reporter construct regulated by this 
element, while other Sox:POU combinations such as Sox2:Brn5 or Sox9:Brn2 were not able to drive this 
expression.  We find that Sox2 and Oct4 can also bind to this site in vivo, as can Sox2 and Brn1 (Figure 
S6a), and confirm that Sox2:Oct4 cannot support expression of Nestin in ESCs but binding of that Sox2 
and Brn1 is compatible with expression in NPCs (Figure S6b).  This suggests that while Sox2:Oct4 can 
drive expression utilizing this element in vitro, in vivo this pairing may be acting as a pioneer factor 
module for this enhancer, to be later replaced by Sox2:Brn1 in NPCs in order to active this element.  
Thus, binding of Sox2 with different partner POU factors may influence the functional consequence of 
this interaction with a genomic locus. 
The majority of Sox2:Brn targets are not shared by Sox2:Oct4, so we therefore sought to 
understand what mechanism could underlie this selection.  Given that we identified similar Sox and 
Octamer consensus motifs bound in both cell types, we hypothesized that analysis of the motif 
configuration at the global level between Sox2 and the cell-type-specific POU factors, Oct4, Brn1, and 
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Brn2 may reveal mechanistic insights into how these factors recognize distinct genomic sites. Consistent 
with previous data, we determined that Sox2 binding occurred within close proximity of Oct4 binding in 
ESCs at many genomic targets (Figure 3a). In contrast, regions of Sox2 and Brn1 or Brn2 co-occupancy 
were often more widely distributed (Figure 3b, c). For example, the Jam2 locus was bound by Sox2 and 
POU factors in both ESCs and NPCs.  Sox2 and Oct4 occupied a region upstream of the TSS in close 
proximity to each other, while the peaks of Sox2 binding in NPCs was approximately 200 bp away from 
peaks of Brn1 and Brn2 binding (Figure 3d).   Moreover, many known Sox2:Oct4 target loci harbor a 
composite Sox-Octamer motif, consisting of a 5’ Sox site followed by a 1 bp spacer and then a 3’ 
Octamer site, and we observed that this 5’ Sox-Oct composite motif is the most frequent configuration at 
Sox2:Oct4 ESC targets (Figure 3e).  This configuration was also the most frequently observed in 
Sox2:Brn1 and Sox2:Brn2 co-bound regions, but in addition a significant fraction of Sox2:Brn1 and 
Sox2:Brn2 target regions displayed the reverse orientation (3’ Sox, 5’ Octamer) with distances of 5 bp 
and 24 bp between the motifs (Figure 3f, g).  For example, a Sox2:Brn1 target region within an intron of 
the Dhrs2 locus, encoding a widely expressed metabolic gene, contained a Sox:Octamer composite motif 
in the -24bp configuration, and was not bound by Sox2:Oct4 in ESCs (Figure 3h).  These data suggest 
that differences in target selection by Sox2 and its cell-type-specific partner factors may be in part 
dictated by differential Sox:Oct motif preferences by Sox2:Oct4 vs. Sox2:Brn1 or Sox2:Brn2.   
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Figure 3. Motif configuration affects both the consequence and the occurrence of binding by Sox2 
and cell-type specific POUs. (a-c) Distribution of distances in base pairs between peaks of Oct4 (left) 
Brn1 (middle) and Brn2 (right) from Sox2 bound peaks.  (d) Gene plots at the Jam2 locus.  y-axis 
corresponds to reads per million.  (e-g) Distribution of distance in base pairs of Sox and POU motifs 
within Sox2:Oct4, Sox2:Brn1, and Sox2:Brn2 bound regions.  Green plot represents 3’Sox-Octamer-5’ 
configuration, while the blue plot represents the reverse orientation. (h) Gene plots at the Dhrs2 locus.  
Inset is genomic sequence containing Sox and Octamer motifs under peaks of Sox2 and Brn1.  y-axis 
corresponds to reads per million.   
 
Brn2 expression in ESCs leads to accelerated neural differentiation 
We next sought to understand what the functional consequences of Sox:Brn binding to enhancers 
could be.  Previous studies from our lab and others have shown that epigenetic marks associated with 
distal enhancers vary more widely than those associated with promoters (Heintzman et al., 2007, 2009; 
Creyghton et al., 2010), indicating that they play a crucial role in regulating cellular identity.  Thus, we 
reasoned that Sox2, Brn1, and Brn2, through their preference for binding distal enhancers, would be 
strong regulators of cell state.  To test this idea, we generated ESC lines that harbored a tetracycline 
inducible Brn2 transgene and assayed their potential to differentiate into NPCs by culturing then in 
serum-free medium without LIF (Ying et al., 2003) (Figure S7a, b).  ESCs showed distinct morphological 
changes from round cells that grow in colonies in control cultures to polarized, Nestin positive cells at 
Day 1 of differentiation when exposed to ectopic Brn2, but took several days to accomplish this transition 
in control cells (Figure 4A).  Consistent with this, neural lineage genes such as Nestin and Sox1 were up-
regulated in Brn2-induced, differentiating ESCs (Figure 4B).  Notably, Brn2 expression did not affect the 
normal transition in the levels of Oct4, Sox2, and Nanog compared to control cells indicating that Brn2 
cannot completely overcome the Oct4:Sox2 autoregulatory circuitry present in ESCs (Figure 4B; Figure 
S7C).  Thus, Brn2 can induce ESCs to differentiate towards the neural lineage, suggesting that the 
genomic binding pattern of Brn2 at distal enhancers functions to enforce neural identity. 
In order to determine the mechanism by which Brn2 affects this change, we performed ChIP-Seq 
on Brn2 at Day 2 of this time course to define a set of genomic targets which may be occupied ectopic 
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Brn2.  We also performed ChIP-Seq on Sox2 in these cells to test the hypothesis that ectopic Brn2 may 
collaborate with the endogenous Sox2 in these cells to co-regulate genomic targets, analogous to the 
scenario in NPCs.  We defined 8,401 genomic regions enriched by Brn2 ChIP and 12,362 genomic 
regions enriched by Sox2 ChIP at high confidence in these cells.  As in ESCs and NPCs, the majority of 
Sox2 and Brn2 occupied regions were distal to annotated TSS (Figure S7D).  Globally, ectopic Brn2 
targets correlated with those bound by Sox2 and Brn2 in NPCs (Figure 4C), while Sox2 targets in these 
cells correlated with Sox2:Oct4 ESC targets (Figure 4C).  However, we were able to define 
approximately 1,500 regions which were co-occupied by ectopic Brn2 and Sox2 in these cells.  We then 
compared these regions to Sox2-bound regions in ESCs, NPCs, and control day 2 differentiating ESCs 
without ectopic Brn2 to test whether ectopic Brn2 was utilizing endogenous Sox2:POU circuitry with 
Sox2 to affect cell fate (Figure 4D).  Indeed, we found that ectopic Brn2:Sox2 occupied regions bound by 
Sox2 in ESCs (4D, green, purple).  Many of these regions were also bound by Sox2 in control 
differentiating ESCs without Brn2, suggesting that Sox2 occupancy of these regions was Brn2 
independent (data not shown).  Interestingly, ectopic Brn2 and Sox2 also occupied regions not bound by 
Sox2 in ESCs.  A subset of these regions were Sox2 targets in NPCs (4D, dark blue), whereas others were 
specific to these cells and bound in neither ESCs nor in NPCs (4D, orange).  A fraction of these regions 
were also bound by Sox2 in control differentiating ESCs which did not have ectopic Brn2 (4D, red, cyan), 
but the majority were bound only in cells with ectopic Brn2.  This suggests that ectopic Brn2 was able to 
bind to these regions and recruit Sox2, suggesting it may act as a pioneer factor. 
We then tested whether the binding of ectopic Brn2 and Sox2 influenced the expression of the 
closest gene to the co-bound region.  We measured the expression of the nearest genes to three classes of 
ectopic Brn2:Sox2 bound regions: those which were occupied by Sox2:Oct4 in ESCs and Sox2:Brn2 in 
NPCs (Class I), those which were occupied only in NPCs by Sox2:Brn2 (Class II), and regions which 
were only bound by Brn2 in NPCs (Class III) (Figure 4E).  In all three contexts, ectopic Brn2 was 
sufficient to induce expression of some of these genes (Figure 4F, S7E), indicating that ectopic Brn2 can 
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utilize diverse Sox2-dependant and independent mechanisms to activate gene expression and influence 
cell identity.   
66 
 
 
Figure 4. Brn2 biases ES cells towards neural differentiation.  (a) Immunocytochemistry of Nestin 
(green) in ES cells induced to differentiate in adherent cultures with or without ectopic Brn2. (b) 
Quantitative Real-Time PCR of the indicating genes in ESCs with (black lines) and without (gray lines) 
ectopic Brn2 expression through differentiation.  y-axis represents relative expression normalized to 
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GapDH in 3 biological replicates, measured in triplicate.  ESC time point is ESCs without doxycycline, 
and d1-d9 time points represent time in differentiation medium.  (c) Correlation matrix comparing ectopic 
Brn2 binding at Day 2 of differentiation and Sox2 at Day2 in Brn2 induced cells with the binding of Sox2 
and Brn2 in NPCs and Sox2 and Oct4 in ESCs.  (d) Breakdown of the fractions of ectopic Brn2:Sox2 co-
occupied regions which are also bound by endogenous Sox2 in ESCs, NPCs, or Day 2 of differentiation 
in control cells.  (e) Gene plots depicting representative loci distal to the start sites of PDGFC, Lrrn1, and 
Tcf12 constituting three classes (Class I, II, and III, respectively) of ectopic Brn2:Sox2 co-occupied 
regions. (f) Quantitative Real-Time PCR time course of expression of genes in each class in control and 
Brn2 expressing differentiating ESCs. y-axis represents relative expression normalized to GapDH in 3 
biological replicates, measured in triplicate.  * = p-value < 0.05,  * = p-value < 0.01 ANOVA with 
Bonneferoni correction 
 
Discussion 
In this study, we investigated the genome-wide binding profiles of the HMG-box transcription 
factor Sox2 in two cell types in which it is thought be a master regulator of cell identity:  pluripotent 
embryonic stem cells and multipotent neural precursor cells.  How this master regulator can control 
cellular identity in two distinct stem cell types has been an unsolved question for some time.  In ESCs, 
Sox2 was known to partner with the POU factor Oct4 to stabilize its interaction with many genomic 
targets.  These targets included both genes involved in ESC identity and lineage commitment factors 
which would become active only later in development, indicating that it could act as a pioneer factor.  
How Sox2 could function in the cellular environment of an NPC which lacks Oct4, and whether Sox2 
acted both to activate gene expression in some contexts and poise expression in others was not clear.  
Recently, analysis of Sox3 in NPCs revealed that a subset of Sox2 target regions in ESCs linked to 
repressed genes involved in NPC identity were bound by Sox3 in NPCs (Bergsland et al., 2011).  This 
study also suggested that Sox2 may co-occupy many Sox3 bound sites in NPCs.  These genes in turn fell 
into two classes: those which were expressed in NPCs, and those which were repressed in NPCs and were 
later bound by Sox11 as these cells completed their differentiation towards mature neurons.   Our data 
confirms that indeed Sox2 as well as Sox3 seems to also act as a pioneer factor in NPCs.  This study left 
open one question: How can Sox2 play such a key role in two very different cell types yet bind many of 
the same genomic targets in these cells?  Another genome-wide analysis of Sox2 in NPCs revealed its co-
localization with the ATP-dependent histone remodeler Chd7, indicating that Sox2 interfaces with this 
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epigenetic regulator in modulate transcription (Engelen et al., 2011).  While this interaction revealed a 
possible mechanism for Sox2 function, it is not known if an interaction with a chromatin remodeler like 
Chd7 could stabilize ternary complex formation between itself, Sox2, and a DNA target in the same way 
transcription factors such as Oct4 have been shown to do.  Thus the question remains: How can Sox2 bind 
tightly to genomic targets in NPCs in the absence of Oct4? 
To begin to answer these open questions, we performed ChIP-Seq on Sox2 in ESCs and NPCs.  
We confirmed that in ESCs, Sox2 bound the promoters of genes encoding transcription factors and 
epigenetic regulators.  In NPCs Sox2 also occupied the promoters of genes in these classes, but in 
addition genes involved in RNA splicing, which is known to play a major role in the development of the 
CNS (Boutz et al., 2007; Grabowski, 2011).  We also confirmed that the majority of Sox2 bound regions 
were distal to known TSSs in both cell types, and in support of the notion that these regions might 
represent distal enhancers, showed that a significant fraction of these non-TSS associated Sox2 bound 
regions correlate with known marks of enhancers, H3K4me1 and H3K27Ac.  Consistent with the idea 
that Sox2 may act as a pioneer factor to prime enhancers for later activation (Smale, 2010; Wegner et al., 
2011), we showed that a large number of the enhancers are H3K4me1+ but H3K27Ac-, a state 
characteristic of poised enhancers.  Thus, Sox2 occupied two classes of targets: regulatory regions highly 
expressed genes involved in NPC state, and poised genes involved in later lineage commitment. 
  Sox2 occupied almost mutually exclusive sites in ESCs and NPCs, despite using the same DNA 
motif to recognize these genomic targets.  How could this selection be mediated?  Given that Sox proteins 
frequently bind target loci with partner factors, exemplified by the partnership of Sox2 in ESCs with the 
POU factor Oct4, we tested Sox2-bound regions in NPCs for enrichment of the DNA binding motifs of 
known transcription factors from the TRANSFAC database.  Interestingly, we found the recognition site 
for another POU factor, Brn2, enriched in these regions.  Given the evolutionary conservation of the 
Sox:POU interaction, the co-expression of Sox2, Brn2 and the closely related Brn1 in neurogenic regions 
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of the brain, and the neurodevelopmental defects associated with loss of function of Brn1 and Brn2, we 
hypothesized that these neural POU factors could partner with Sox2 in NPCs. 
To test this, we performed ChIP-Seq on Brn1 and Brn2 in NPCs.  Interestingly, while Sox2 co-
occupied most binding sites with Oct4 in ESCs, we found that the interaction between Sox2 and Brn1 and 
Brn2 was enhancer specific.  Many of these enhancers were active (H3K27Ac+), and genes linked to 
them included regulates of the NPC state such as Notch1.  These data validate two described enhancers 
bound by Sox2, Brn1, and Brn2 in neurogenic regions of the brain, the Nes30 enhancer of the Nestin 
locus (Tanaka et al., 2004) and the 3’ enhancer of the Sox2 locus, SRR2 (Miyagi et al., 2006), and extend 
them to thousands of neural specific enhancers.  Interestingly, both of these enhancers are also bound by 
Sox2:Oct4 in ESCs; SRR2 is maintained as an active enhancer, while at the Nestin locus, Sox2:Oct4 may 
be acting as pioneer factors to facilitate Sox2;Brn1 binding in NPCs.  Thus, cell-type-specific POU 
factors collaborate with Sox2 to hand off targets during developmental transitions. Another subset of 
elements were poised, H3K4me1+/H3K27Ac- enhancers which were linked to genes which encode 
regulators of development passed the NPC state.  This suggests that Brn1 and Brn2, like Sox2, may be 
acting as pioneer factors in NPCs.  Interestingly, the POU factor Brn5, like Sox factors Sox11 and Sox21, 
is expressed in differentiated neurons and some glia in the adult CNS and thought to play a role in 
regulating cell state in these tissues (Okamoto et al., 1993; Andersen et al., 2003; Cui et al., 1997, 1998; 
Wu et al., 2001; Sandberg 2005; Ferletta et al., 2011).  The comparison of the genome-wide binding 
profiles of Brn5 and Sox21 in neurons to Sox11 in these cells and Sox and POU factors in earlier 
developmental stages will be instrumental in clarifying the precise roles of these factors in priming 
enhancers for later developmental decisions in the neural lineage.   
Many recent studies have suggested that enhancers may play a crucial role in regulating cellular 
state, so we hypothesize that Sox2, Brn1, and Brn2, through their preferential association with these 
elements, would be potent regulators of cellular identity.  To test this, we generated ESCs harboring a 
tetracycline inducible Brn2 transgene and assayed the potential of these cells to differentiate into NPCs, 
70 
 
and showed that Brn2 accelerated this process.  This observation is supported by other experiments in the 
literature which suggest that Brn2 is an early marker of neural commitment.  In retinoic acid induced P19 
embryonic carcinoma cells, Brn2 is induced early as these cells adopt the neural fate in vitro (Jin et al., 
2009).  Interestingly, another study showed that by switching the suite of nuclear importins, which 
regulate traffic between the cytoplasm and the nucleus, expressed in ESCs, these cells could be biased 
towards differentiating towards the neural fate due to differential import of Oct4 and Brn2 by these 
factors (Yasuhara et al., 2007).   Finally, a recent study in vivo demonstrated that Sox2 expression is 
maintained upon differentiation of epiblast to neural plate by a hand off of a Sox2 enhancer from 
Sox2:Oct4 to Sox2:Brn2 (Iwafuchi-Doi et al, 2011).  Mechanistically, we showed that ectopic Brn2 can 
recruit Sox2 to new enhancer targets in the cells, and this co-binding is sufficient to induce expression of 
nearby genes.  Thus, Brn2 may act as a specificity factor of Sox2, allowing it to bind target loci to which 
it cannot bind alone. 
The fact that POU factors directed Sox2 to cell-type-specific targets in both ESCs and NPCs 
raised a question:  If Sox2 uses the same recognition motif in both cell types, and Oct4, Brn1, and Brn2 
all bind highly similar Octamer motifs, how is this context specific binding pattern achieved?  To address 
this paradox, we sought to refine our understanding of the precise rules of Sox2:Oct4, Sox2:Brn1, and 
Sox2:Brn2 binding.  We found that while the motifs bound by the factors were highly similar, the 
configuration of the Sox and Octamer motifs in Sox2:Brn1 and Sox2:Barn2 target regions differed 
significantly.  At some loci, as in the case of Nestin, this distinction manifested itself by the locus being 
bound by Sox2:Oct4 in ESCs but not activated, and only becoming activate upon differentiation to and 
NPCs and the binding of the element by Sox2:Brn1.  In other cases, the distinct orientation of Sox and 
Octamer motifs in Sox2:Brn1 and Sox2:Brn2 regions precluded binding by Sox2:Oct4 in ESCs.  This 
sensitivity to the orientation of Sox and Octamer motifs has been noted at several individual targets of 
Sox and POU factors (Ambrosetti et al., 1997; Botquin et al., 1998; Kuhlbrodt et al., 1998; Tomoika et 
al., 2002; Remenyi et al., 2003 Tanaka et al., 2003; Reiprich et al., 2010), but this is the first time this 
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observation has been extended genome wide.  This suggests that allosteric interactions between 
transactivation domains of Sox and POU factors may be key in stabilizing ternary complexes between 
them and DNA targets globally, examples of which have been observed at individual targets of Sox2:Oct4 
in ESCs (Ambrosetti et al., 2000).   
This set of experiments demonstrates that collaboration between Sox and POU factors controls a 
subset of distal enhancers from the pluripotent ESC state to the multipotent NPC state.  Structural 
differences in the DNA sequence of these enhancers as well as the intrinsic characteristics of the specific 
Sox and POU factors expressed in a given cell type along this pathway likely contribute to the diversity of 
gene expression programs observed during this transition.  Taken together with other recently published 
work, these data suggest that this Sox:POU interaction may regulate this pathway from the earliest stages 
of development all the way through terminal, neuronal differentiation.  Going forward, understanding the 
combinatorial code regulation development in this and other lineages will be key to understanding how 
enhancers are regulated in metazoan development. 
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Supplemental Figure Legends 
Figure S1. Correlation of ChIP-Seq datasets 
Figure S2. Expression of POU factors in ESCs and NPCs. Mean, RMA normalized values from highest 
detected probe set for each gene across three biological replicates interrogated with Affymetrix Gene 
Expression arrays are presented.   
Figure S3. (a) Sequences similar to the canonical octamer motif enriched in Oct4, Brn1, and Brn2 targets 
by MEME analysis. (b) Breakdown of POU factor binding to promoters and enhancers. (c) GOSTAT 
gene ontology analysis of Brn1 and Brn2 bound poised and active enhancers. 
Figure S4. (a) Venn diagram depicting overlap between Sox2, Brn1, and Brn2 enhancer associated bound 
regions in NPCs. (b) Venn diagrams depicting overlap between Sox2 and Oct4 in ESCs and Sox2, Brn1, 
and Brn2 at promoters and enhancer at the level of genes. (c) Gene plots of Sox2 and Oct4 binding to 
indicated loci.  y-axis corresponds to reads per million. Scale bar corresponds to 1 kb.   
Figure S5. Mann-Whitney U analysis of transcription factor motifs enriched in Sox2 and Brn1 and 
Brn2 bound regions in NPCs (left) and Sox2 and Oct4 bound regions in ESCs. Sox2 and POU motifs 
have been excluded. P-values reflect enrichment in Sox2:Brn2 overlapping regions. Gene whose 
names are in black are detected expressed in their given cell type while those in green are not 
detected. 
Figure S6. (a) Gene plots showing density of Oct4 and Sox2 in ESCs and Sox2 and Brn1 in NPCs at a 
validated enhancer of the Nestin locus. y-axis corresponds to reads per million.  Scale bar corresponds to 
1 kb.  (b) Q-PCR analysis of Nestin expression in ESCs and NPCs.  Error bars represent standard 
deviation across three technical replicates. 
Figure S7. (a) Schematic of transgenic system to inducibly express Brn2 from the Col1A1 locus (adapted 
from Hochedlinger et al., 2005) (b) Experimental design.  Adherent Brn2 targeted and control ESCs were 
exposed to dox, then 24 hours later the medium was switched to differentiation medium.  The next day 
cells were harvested as the Day 1 time point.  (c, e) Quantitative Real-Time PCR time course of Nanog 
and Brn2 (c) and genes in Class I, II, and III (e) in control (gray) and Brn2 induced (black) differentiating 
ESCs. y-axis represents relative expression normalized to GapDH in 3 biological replicates, measured in 
triplicate.  * = p-value < 0.05, * = p-value < 0.01 ANOVA with Bonneferoni correction. (d) Fraction of 
bound regions mapping within 1 kb of TSSs vs. distal to TSSs for indicated factors in d2 cells. 
 
Methods 
Cell growth and culture conditions 
C57/BL6-129JAE (V6.5) mouse embryonic stem cells were cultured in DMEM supplemented with 10% 
Fetal Bovine Serum (Hyclone), 1,000 units/ml leukemia inhibitory factor (LIF) 0.001 % β-mercapto-
ethanol (Sigma, M7522)., 100 μM nonessential amino acids (Invitrogen, 11140-050), 2 mM L-glutamine 
(Invitrogen, 25030-081), 100 U/mL penicillin, 100 μg/mL streptomycin (Invitrogen, 15140-122), Neural 
progenitors were derived via in vitro differentiation from V6.5 ES cells as described (Okabe et al., 1996).  
Briefly, embryoid bodies (EBs) were formed from V6.5 ES cells by culturing them in suspension without 
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LIF, and on day 4 these EBs were plated back onto adherent dishes.  After 24 hours selection for neural 
precursors began by switching the medium to ITSFn, which contains 1:1 DMEM:F12 (Ham) 
supplemented with 5 μg/ml insulin (Invitrogen I6634), 50ug/ml transferrin (Sigma T2036), 0.5uM 
Sodium Selenite (Sigma S1382), 5ug/ml fibronectin (Invitrogen 33016015) and 100 U/mL penicillin, 100 
μg/mL streptomycin (Invitrogen, 15140-122).  After 8 days cultures were trypsinized to single cells, and 
trypsin was quenched with serum-containing medium.  They were then passaged on to 15 μg /ml 
polyornithine (Sigma P3655) and 1 μg/ml laminin (Invitrogen 23017) coated dishes and cultured from 
that point onwards in N3 medium, which contains 1:1 DMEM:F12 (Ham), 25 μg /ml insulin, 50ug/ml 
transferrin, 0.5uM Sodium Selenite, 100 U/mL penicillin, 100 μg/mL streptomycin, 20nM progesterone 
(Sigma 8783), 100nM putricine (Sigma 5780), 5ng/ml bFGF (R and D Biosystems 233-FB-025) and 
20ng/ml EGF (R and D Biosystems 236-EG-200).  In the presence of growth factors these the vast 
majority of these cells can be labeled homogenously with antibodies against Nestin, Sox2, and Pax6. 
Upon growth factor withdrawal, the cells differentiate into TUJ1-positive neurons. 
 
Chromatin Immunoprecipitation 
Sox2 NPC ChIP, Brn1 NPC ChIP, Brn2 NPC ChIP 
ChIP was performed as described (Lee et al., 2006).  Briefly, approximately 5x10
8
 cells were cross-linked 
and chromatin fractions were isolated.  Chromatin was sheared by sonication, whole cell extract (WCE) 
was removed, and ChIP was performed using the following antibodies: 
Sox2 R and D Systems AF2018 goat polyclonal 
Brn1 Santa Cruz Biotechnology sc-6028 goat polyclonal 
Brn2 Santa Cruz Biotechnology sc-6029 goat polyclonal 
ChIP and WCE DNA was then purified and genomic libraries were prepared using the ChIP-Seq Sample 
Prep Kit (Illumina 1003473) according to the manufacturers protocol (Illumina 11257047) for selecting 
library fragments between 200 and 350 bp. Samples were run using the GA2X genome sequencer (SCS 
v2.6, pipeline 1.5). 
Brn2 and Sox2 ChIP in differentiating ESCs 
ESCs at day 2 of differentiation were cross-linked and harvested as above.  The same Sox2 and Brn2 
antibodies were used.  Approximately 5x10
7
 formaldhyde-crosslinked cells were lysed and as above on an 
IP-Star (Diagenode).  Chromatin was sonicated on the Bioruptor (Diagenode) to an average size of 0.2-1 
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kb. Sox2 ChIP was performed with 3 μg of antibody (above) using the IP-Star Automated System 
(Diagenode) and 2.5% of chromatin was used for each whole cell extract (WCE). Following reversal of 
crosslinks, sample and WCE DNA was purified.  ChIP DNA was dissolved in water and placed on the 
SPRI-TE (Beckman Coulter) for Illumina sample preparation. ChIP-Seq and WCE libraries were 
barcoded and multiplexed on the HiSeq 2000 (Illumina). 
 
Sox2 ESC 
Approximately 5x10
7
 formaldhyde-crosslinked ESCs were lysed and as above on an IP-Star (Diagenode).  
Chromatin was sonicated on the Bioruptor (Diagenode) to an average size of 0.2-1 kb. Sox2 ChIP was 
performed with 3 μg of antibody (above) using the IP-Star Automated System (Diagenode) and 2.5% of 
chromatin was used for each whole cell extract (WCE). Following reversal of crosslinks, sample and 
WCE DNA was purified.  ChIP DNA was dissolved in water and placed on the SPRI-TE (Beckman 
Coulter) for Illumina sample preparation. ChIP-Seq and WCE libraries were barcoded and multiplexed on 
the HiSeq 2000 (Illumina). 
ChIP-Seq Data Analysis 
Images acquired from the Illumina/Solexa sequencer were processed using the bundled Solexa image 
extraction pipeline.  Sequences were aligned using Bowtie software (http://bowtie-
bio.sourceforge.net/index.shtml) using murine genome NCBI Build 36 and 37 (UCSC mm8) as the 
reference genome with default settings for mismatch tolerance, non-unique mapping events, etc.  Analysis 
of our sequence data was done based on previous models (4, 5). Sequences were extended +200 bp for 
transcription factors and  allocated in 25 bp bins (1.05×10
8
 bins total). Statistically significant enriched 
bins were identified using a Poissonian background model, generally with a p-value threshold of 10
-8
 to 
minimize false positives. We used an empirical background model (whole cell extracts (WCE)) that 
require genomic bins to be enriched at least 5 fold above background to correct for non-random 
enrichment observed previously.  Genes with enriched regions within 1kb of their start sites ware called 
bound at their promoters, while enriched regions which were within 1 kb of peaks of H4K4me1 or 
H3K27Ac  (Creyghton et al., 2010) called bound to enhancers and were assigned the closest gene up or 
downstream. 
Gene ontology 
Gene ontology analysis was performed using GOstat (http://gostat.wehi.edu.au/cgi-bin/goStat.pl) or the 
GREAT algorithm (http://great.stanford.edu/) as indicated.  GOSTAT was performed using the mgi 
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(mouse) GO annotation database.  For enhancer locations from each cell type we selected the closest gene 
either upstream or downstream.  GREAT analysis was preferred using mm9 bound regions obtained by 
lift-over of mm8 called regions, using the Galaxy web tool (main.g2.bx.psu.edu/). 
Gene Plots 
 Single gene ChIP-Seq density plots were generated using the UCSC Genome Browser 
(http://genome.ucsc.edu/cgi-bin/hgGateway).  Wiggle files were generated from ChIP-Seq reads and 
density was normalized to reads-per-million.  Published datasets were also used to correlate Sox2 to 
epigenetic marks (Mikkelsen et al., 2007; Creyghton et al., 2010).  These wiggle files were uploaded to 
the genome browser and tracks of ChIP-Seq density at selected loci were downloaded and formatted for 
inclusion in the manuscript. 
Unbiased Motif Search 
MEME (meme.sdsc.edu/) was used to find DNA sequences enriched in Sox2 bound regions in ESCs and 
NPCs.  Plus/minus 75 base pairs surrounding peaks of minimum peak height of 100 of Sox2 enrichment 
above were input into MEME and motif logos were generated from position weight matrices obtained. 
RNA isolation and microarray analysis 
Three biological replicates for V6.5 ESCs and V6.5-derived NPCs were prepared, hybridized to 
arrays, and analyzed independently, then normalized and compared to yield final expression values.   
 RNA was isolated using Trizol reagent (Invitrogen) according to the manufacturer’s protocol and 
DNAse treated using the DNA-Free RNA kit (Zymo Research R1028).  Samples were then prepared for 
Affymetrix GeneChip Expression Array analysis.  5 µg total RNA was used to prepare biotinylated cRNA 
according to the manufacturer’s protocol (Affymetrix One Cycle cDNA Synthesis Kit). Briefly, this 
method involves SuperScript II-directed reverse transcription using a T7-Oligo(dT) Promoter Primer to 
create first strand cDNA. RNase H-mediated second strand cDNA synthesis is followed by T7 RNA 
Polymerase directed in vitro transcription, which incorporates a biotinylated nucleotide analog during 
cRNA amplification. 
Samples were prepared for hybridization using 15 µg biotinylated cRNA in a 1X hybridization 
cocktail according the Affymetrix hybridization manual. Additional hybridization cocktail components 
were provided in the Affymetrix GeneChip Hybridization, Wash and Stain Kit.  GeneChip arrays (Mouse 
430) were hybridized in a GeneChip Hybridization Oven at 45C for 16 hours at 60 RPM. Washing was 
done using a GeneChip Fluidics Station 450 according to the manufacturer’s instructions, using the 
buffers provided in the Affymetrix GeneChip Hybridization, Wash and Stain Kit.  Arrays were scanned 
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on a GeneChip Scanner 3000 and images were extracted and analyzed using GeneChip Operating 
Software v1.4.   
Biological replicates were RMA normalized using updated annotation from the BrainCDF the site 
remapped from Ensembl Gene ID to Gene Name from Biomart, and the mean intensity for each probe 
across three arrays was calculated.  Maximum probe mean values for each gene were taken as gene 
expression levels.  Box and Violin plots were constructed depicting median values as center line, and 
bottom and top of the box representing  the 25
th
 and 75
th
 percentiles, respectively.  Whiskers depict  + 
1.5*IQR (interquartile range) for top, -1.5*IQR for the bottom.   
Correlation of ChIP-Seq Datasets 
Comparison of ChIP-Seq datasets was performed using a similarity metric based on a correlation 
coefficient (Bilodeau et al., 2009).   This analysis generates a correlation coefficient between zero and one 
reflecting the similarity of genomic regions occupied in two datasets. A value of one would reflect total 
overlap between two datasets while a value of zero would reflect overlap expected by random association.  
Values in Figure S1 were generated in this way.  The matrix in Figure 2C was generated by clustering 
these data using hierarchical clustering along the horizontal and vertical axis with an average linkage 
similarity metric using the software Cluster3.0 (http://bonsai.hgc.jp/~mdehoon/software/cluster/).  This 
matrix was visualized using Java TreeView (http://jtreeview.sourceforge.net/). 
Transgenic ES cell generation 
ES cells which inducibly overexpress mouse Brn2 were generated using the “flp-in” system described 
previously (Beard et al., 2004).  Briefly, Brn2, cDNA were cloned into pBS31, which contains the PGK 
promoter followed by an ATG start codon and an frt site, a splice acceptor-double polyA cassette, the 
tetracycline operator followed by a CMV minimal promoter, a unique EcoRI site for subcloning, and an 
SV40 polyA signal.  These constructs were electroporated into KH2 ES cells, which harbor an M2-rtTA 
gene into the ROSA26 locus  a construct containing a frt-flanked PGK-neomycin-resistance gene 
followed by a promoterless, ATG-less hygromycin-resistance gene downstream of the Col1a1 locus.  To 
flip-in the tetracyclin-responsive Brn2 constructs into these cells, pBS31 plasmids was co-transfected 
with a plasmid expressing the FlpE recombinase, and ES cells were selected for hygromycin resistance.  
Cells were treated with the tetracycline analog doxycycline to achieve induced expression. 
 
Brn induced neural differentiation of ES cells to NP cells 
Dox inducible Brn2 expressing ES cells and rtTA only ES cells were passaged off feeders in ES medium 
plus 2 μg/ml Dox.  Twenty four hours later the medium was switched to N2B27 plus Dox.  Cells were 
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fixed with 4% paraformaldehyde in PBS and stained with anti-Nestin (Developmental Hybridoma Bank) 
and DAPI, and assayed by Quantitative Real-Time PCR (below) at 24 hour intervals. 
 
Quantitative Real-Time PCR 
Trizol-isolated RNA from three biologically independent samples for each sample was purified, DNAse 
treated (DNA free RNA Kit, Zymo Research) then reverse transcribed using a First Strand Synthesis Kit 
(Invtirogen). cDNA was analyzed by quantitative PCR analysis performed in technical triplicate using an 
ABI Prism 7000 (Applied Biosystems) with Platinum SYBR green qPCR SuperMix-UDG with ROX 
(Invitrogen).  The following primers were used: 
 
 
Forward (5'-3') Reverse (5'-3') 
Oct4 ACATCGCCAATCAGCTTGG AGAACCATACTCGAACCACATCC 
Sox2 ACAGATGCAACCGATGCACC TGGAGTTGTACTGCAGGGCG 
Nestin TCTACAGGCAGCGCTAACAGTC TCCCCTAACTCATCTGCCTCAC 
Sox1 AGTGGAAGGTCATGTCCGAGG GCCAGCGAGTACTTGTCCTTCTT 
Brn2 AGCAGTTCGCCAAGCAATTC CGAGAACACGTTGCCGTACA 
GapDH TTCACCACCATGGAGAAGGC CCCTTTTGGCTCCACCCT 
Apba2 ACGGACAGAGTGTGGTAGCC CGTGAGGAGCCTAAACATGG 
Cops2 CTGATGTGGAGAGCTTGCTG CACCCCTCTTCTGATGATCC 
Id4 ACTCACCCTGCTTTGCTGAG AGAATGCTGTCACCCTGCTT 
Irx3 AGTGCCTTGGAAGTGGAGAA CGTCCAGATGGTTCTGTGG 
Irx5 ACAGAAGCCCGAGGACAAG TAAAATCCGAGTCGCTGAGG 
Jag2 CGTGGCTGCTATCACTCAGA AGCCACAGCACACTGAACAC 
Kirrel3 TGTGCCATCCCTGAATATGA TGCTCTCCTGAGAGGTGGTT 
Lemd1 ATTCACACCTGGCCCAATAC TCACTGTCATCGCTGTCCTC 
Lrrn1 GTCCTCATCCTCCGGCTAGT CACAGGTCCTTGTGGGAGTT 
NfIX CTTTGTGACGTCTGGGGTCT TGTAGTAGCTGGGGCTCTCC 
PDGFC GTGGAGGAAATTGTGCCTGT CCCTTGACTCCAGTTTTTGG 
Sox21 TGGTGTTTGCTTTGCACTTC GGAGGGAGGAAGGATGAGAC 
Tcf12 CCGTGGCAGTCATCCTTAGT GCTGACGCAGCAGAGACTTT 
Zic1 CCTTTGCAAGATGTGCGATA CTGTGAGCCCTGAGAAGAGG 
 
Data were extracted from the lineage range, and the standard curve method was used to obtain relative 
expression values.  Technical replicates were averaged, then biological replicates were averaged.  
Statistical significance was determined using Graphpad Prism to perform an ANOVA with Bonnferroni 
Correction for multiple testing. 
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Overrepresented motifs within Sox2 bound sites. 
Sox2-bound regions (in ES and NP cells) regions were examined for motif overrepresentation. Sox2-
bound regions were defined as 100 base pair windows around the peak.  We used a hypothesis-based 
approach to identify known protein-DNA recognition elements enriched in each dataset. The set of 
hypotheses are derived from all vertebrate position specific scoring matrices (PSSMs) from TRANSFAC 
(Wingender et al., 1996) filtered for sufficient information content (IC>8 total bits). The final set of 
motifs was preclustered based on pairwise distance by KL-divergence of the PSSMs using Affinity 
Propagation. The TAMO programming environment (Gordon et al., 2005) were used to store the PSSMs 
and calculate the max motif score for each sequence across all k-mers in the sequence for a motif of width 
k). Overrepresentation of motifs in a foreground set of sequences was assessed against a background set 
of randomly generated sequences which matched the size and sequence complexity of the test set using 
the Mann-Whitney Wilcoxon ranked sum test. For each independent motif test, the U statistic and sample 
sizes were used to calculate a p-value for motif enrichment in the foreground set of sequences relative to 
background and the area under the curve for the receiver operating characteristic (AUC ROC). For each 
foreground set of sequences, a background was selected to maximally capture undesirable biases in the 
foreground set of sequences such as GC content, CpG content and TSS proximity.  Out of each cluster, 
the statistics and logo for the most highly enriched motif by minimum p-value was presented. 
Genome-wide distances between Sox2 and cofactors 
Distances between Sox2 bound sites and cofactor bound sites in ESCs and NPCs were calculated as 
follows. Overlapping regions of Sox2 and POU factors were defined as regions with at least 1-bp of 
overlap.  Peaks from these overlapping regions were then used to define distances between factor binding.  
In particular, we calculated distances between Sox2:Brn1 site pairs (NPCs), Sox2: Brn2 site pairs (NPCs), 
and Sox2: Oct4 site pairs (ESCs).  Site pairs were defined by matching each Sox2 bound site to the 
closest cofactor bound site within 200 base.  Distance was calculated as the cofactor chromosomal 
coordinate subtracted from the Sox2 chromosomal coordinate. 
Spacing between motif matches.  
Spacing between Sox and Oct family binding was also determined using a motif-based approach to 
determine whether spatial arrangement of the motifs are exclusive to particular Sox2:POU pairs. In 
particular, the Sox2:Oct4 (ESCs), Sox2:Brn1 (NPCs), and Sox2:Brn2 (NPCs) co-bound regions as 
defined as aforementioned were examined.   Max motif scores were calculated as aforementioned and 
normalized as in Equation 1. Motif matches to Sox were defined as normalized scores greater than 0.85 to 
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a general Sox TRANSFAC matrix, M01308. Similarly, Oct family motif matches were defined as 
normalized scores greater than 0.85 to a general Oct TRANSFAC matrix, M00342.  
For each sequence i and motif j, a motif score sij  :      
           
               
  (1) 
Spacing was defined as the number of base positions between the Oct4 and Sox2 motif matches relative 
to the Sox2 motif match (positive if Oct4 was 3’ to Sox2, negative if Oct4 was 5’ to Sox2).  For each 
sequence, the pair of motif matches could lie in a forward or reverse orientation. Each pair of motif 
matches was designated as forward orientation if both matches were either located on the forward or 
reverse strand. Each pair of motif matches was designated as reverse orientation if one of the matches was 
located on the forward strand and the other on the reverse strand.  For example 
 
Motif Trace Spacing Explanation 
CTTTGTT-N-ATGCAAAT Green +1 Sox is 5' of Oct, both in same 5' to 3' orientation 
ATGCAAAT-N-CTTTGTT Green -1 Sox is 3' of Oct, both in same 5' to 3' orientation 
AACAAAG-N-ATGCAAAT Blue +1 Sox is 5' of Oct, Sox is reverse compliment 
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Chapter Synopsis 
In this Supplemental Chapter, I will provide further analysis of Sox2-occupied regions in ESCs 
and NPCs.  As mentioned in Chapter 2, Sox2 occupied promoter and enhancer regions in ESCs and 
NPCs, and these regions were largely distinct, exhibiting cell type specificity.  I will show more detailed 
analysis of Sox2-bound promoters and enhancers in these cell types here.  Further, while Sox2-bound 
regions were almost mutually exclusive at the global level in ESCs and NPCs, I will highlight key regions 
of overlap between these datasets.  Specifically, Sox2-occupied regions proximal to promoters were more 
likely to be occupied in both ESCs and NPCs that the group of bound regions as a whole.  Further I 
identified a subset of promoters which were bound by Sox2 at distinct sites in ESCs and NPCs, 
suggesting that Sox2 was using distinct sites in the same promoter to regulate common genes.  
Surprisingly, though Sox2-bound enhancer regions were highly divergent, a large fraction of the genes 
associated with Sox2 binding through enhancers in ESCs were linked to new, distinct, Sox2-occupied 
enhancers in NPCs.  These genes tended to be involved in neural development.  These data suggested that 
Sox2 was utilizing distinct enhancers to regulate a set of genes involved in neural development from 
pluripotent ESCs to multipotent NPCs, and was thus regulating neural development from very early in 
embryogenesis though neural commitment. 
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Results 
Sox2 binding to promoter regions in ESCs and NPCs 
 Sox2 is a master regulator of two distinct cell states: the pluripotent ESC state and the multipotent 
NPC state.  In order to ascertain how one transcription factor could control these two cellular programs, 
we mapped the genome-wide binding profile of Sox2 in ESCs and NPCs using chromatin 
immunoprecipitation followed by massively parallel sequencing (ChIP-Seq) to define genes and networks 
of genes which may be regulated by this factor.  We performed ChIP-Seq analysis on Sox2 in ESCs, and 
identified 13,717 Sox2 enriched regions throughout the genome using a Poissonian error model (Marson 
et al. 2008; Methods). This dataset was highly correlated to a previously published one (Marson et al., 
2008), indicating that it is of high quality (Chapter 2).  To probe Sox2 binding in NPCs, we derived these 
cells in vitro using established protocols (Okabe et al., 1996) from genetically identical ESCs as used in 
the above analysis.  Sequencing data of the Sox2-enriched DNA fragments from two biological replicates 
were highly correlated (Chapter 2). This analysis identified 16,685 enriched regions in NPCs.  Using 
these data we then sought to define genes regulated by Sox2 in ESCs and NPCs. 
 Given that proximal promoter regions are known to play a crucial role in gene regulation, we 
examined Sox2-bound regions within 1 kb of annotated transcriptional start sites in ESCs and NPCs to 
gain insight into genes which may be regulated by Sox2.  We confirmed that Sox2 occupied known 
targets in ESCs such as the Nanog and Pou5f1 loci, demonstrating that Sox2 regulates other regulators of 
pluripotency (Figure 1a).  At loci encoding regulators of NPC identity, such as the Hes5 and Dll1 loci, 
(Cau et al., 2000; Ohtsuka et al., 2001; Rocha et al., 2009; Ramos et al., 2010) Sox2 binding was 
observed in NPCs.  Generally, Sox2 targets were highly expressed in the cell type in which they were 
bound (Figure 1b).  While many Sox2 target genes in ESCs were expressed, Sox2 is known to occupy 
poised developmental regulators in ESCs which are repressed and marked by trimethylation of Lysine 27 
on Histone H3 (H3K27me3), a repressive chromatin mark catalyzed by Polycomb group proteins (Loh et 
al., 2005; Boyer et al., 2005, 2006; Lee et al., 2006).  In NPCs, the overlap between Sox2 and H3K27me3 
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was significantly smaller than in ESCs (Figure 1c).  This is in agreement with the fact that while ESCs 
must keep developmental programs for all somatic tissue types competent to be activated, NPCs have 
more restricted developmental potential and thus can maintain fewer poised developmental programs.  
Unbiased MEME motif analysis revealed that the Sox2-bound regions in NPCs frequently harbored an E-
box motif (Figure 1d).  This motif is recognized by the bHLH family or transcription factors, including 
the Myc subfamily and mediators of Notch signaling such as Hes1 and Hes5.  c-Myc is a potent activator 
of transcription, specifically through the ability of c-Myc to release paused RNA polymerase II at 
transcriptional start sites and thereby allowing elongation to occur (Rahl et al., 2010).  N-Myc, L-Myc, 
and c-Myc are expressed in NPCs and important for NPC identity and lineage commitment (Bernard et 
al., 1992; Kuwahara et al., 2010; Wey et al., 2010).  There is a small but statistically significant difference 
in the expression level of Sox2 bound genes in ESCs and NPCs (Figure 1b), which may be related to the 
higher overlap between Sox2 and H3K27me3 in ESCs than in NPCs, and the prevalence of an E-Box 
motif in many Sox2 bound regions in NPCs, which may be bound by strong activators such as c-Myc.  
Taken together, these data indicate that Sox2 is associated with a set of active promoters in ESCs and 
NPCs with distinguishing sequence and epigenetic features. 
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Figure 1 Sox2 binding at promoter regions. a. Gene plots depicting Sox2 ChIP-Seq density at indicated 
regions (mm8 genome).  y-axis reflects reads per million. b. Box and violin plots representing gene 
expression values for genes linked to Sox2-bound promoters.  p-values reflect non-parametric Mann-
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Whitney U test values.  c. Fraction of Sox2 bound promoters which are also marked by H3K27me3.  p-
value reflects hypergeometric distribution. d. E-box motif enriched in Sox2 bound regions in NPCs. 
 
To define the functional classes to which Sox2-bound promoter target genes belonged, we used 
the GREAT algorithm (McLean et al., 2010), a gene ontology tool which tests ChIP-Seq bound regions 
for the function of the nearest genes using binomial test over the input genomic regions, incorporating 
annotations from twenty ontologies (Figure 2).  In ESCs, we find Sox2 was associated with both 
developmental regulators and a large number of broadly expressed housekeeping genes, including the 
promoters of core histone genes. These genes included canonical regulators of pluripotency such as Sox2 
itself, Oct4, and Nanog, and epigenetic regulators such as Mbd3, Set, and Smarc2.  In NPCs, Sox2 also 
occupied the promoters of lineage specific and housekeeping genes.  Many were highly expressed and 
known regulators of the NPC state, such as Pax6, Rfx4 and again Sox2 itself.  The largest group of genes 
regulated by Sox2 in NPCs included regulators of RNA processing. This group includes genes involved 
in mRNA capping, poly-adenylation, RNA editing, and tRNA modification, with the largest subgroup 
comprised of genes involved in mRNA splicing.  Sox2 binds to promoters of over 200 genes encoding 
both general splicing factors, such as components of the splicesome, as well as developmental and tissue 
specific regulators of splicing such as Mbln1 and Mbln2, and PTB and nPTB, which are known to play a 
crucial role in the development of neurons from NPCs (Boutz et al., 2007).  Interestingly, a large group of 
the housekeeping genes regulated by Sox2 in NPCs are confirmed targets of c-Myc in Burkitt’s 
lymphoma (Ben-Porath et al., 2008).  Thus, Sox2 in NPCs regulates lineage specific and housekeeping 
genes, possibly by partnering with c-Myc.  Therefore, in both cell types, Sox2 plays the dual role of 
regulating cell-type specific genes and widely expressed housekeeping genes. 
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Figure 2 GREAT analysis of genes linked to Sox2 bound promoters.  Classes of genes bound by Sox2 
in ESCs (top) and NPCs (bottom).  x-axis reflects binomial raw p-value of enrichment of given category 
against a whole genome background.  Example genes highlighted on the right. 
 
Sox2 Binding at Distal Enhancers 
Interestingly, the majority of Sox2-bound regions in both ESCs and NPCs were not within 1 kb of 
known TSSs (Figure 3a).  Recently it has been shown that H3K4me1 and H3K27Ac mark thousands of 
poised (H3K4me1+/H3K27Ac+) and active (H3K4me1+/H3K27Ac+, H3K4me1-/H3K27Ac+)  
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enhancers in the genome of many cell types, including ESCs and NPCs. In order to ascertain whether 
Sox2 binds near these elements, we surveyed 1 kb up and downstream of peaks of H3K4me1 and 
H3K27Ac enrichment for Sox2-bound regions in ESCs and NPCs.  Indeed, we find that Sox2 binds to 
more regions modified with H3K4me1 and/or H3K27Ac than annotated start sites (Figure 3b).  For 
example, in ESCs Sox2 marks H3K4me1+/H3K27Ac+ regions upstream of the Nanog promoter and 
downstream of its transcriptional stop, in addition to binding the Nanog promoter.  Sox2 also is associated 
with H3K4me1+/H3K27Ac+ regions upstream and within an intron of Jam2, a cell adhesion molecule 
which is thought to be part of a stem cell gene expression signature shared by ESCs, NPCs, and 
hematopoietic stem cells (Ivanova et al., 2006) (Figure 3c).   In NPCs, Sox2 overlaps with H3K4me1 and 
H3K27Ac downstream of Ascl1, a key regulator of neurogenesis, and upstream and within an intron of 
Notch1, a well-characterized regulator of NPCs identity (Figure 3d).  Thus, our data are consistent with 
the notion that Sox2 regulates a larger set of target genes through distal enhancer elements.   
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Figure 3 Sox2 binds more enhancer regions than promoters in ESCs and NPCs.  a. Location analysis 
of Sox2 bound regions relative to known TSSs.  b. Comparison of number of Sox2-bound regions which 
map to promoters versus marked (H3K4me1 and/or H3K27Ac) enhancers, plotted as fraction of total 
promoters and enhancers in the genome.  Numbers above bars reflect raw numbers of bound regions.  c,d. 
Gene plots reflecting Sox2 density at indicated loci (mm8 genome).  y-axis reflects reads per million. 
 
We used nearest neighboring gene analysis to predict the genes associated with putative enhancer 
regions bound by Sox2, as previously described (Heintzman et al., 2009, Visel et al., 2009, Creyghton et 
al., 2010).  In both cell types, Sox2 was associated with more poised enhancers than active enhancers 
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(Figure 4a).  As expected, genes linked to Sox2+, poised enhancers were expressed at a lower level on 
average than genes linked to Sox2+, active enhancers (Figure 4b,c).  Since the genes in this class were 
lowly expressed in the cell type in which they were bound by Sox2, we sought to define in which tissues 
these genes would become expressed.  We used the GREAT algorithm to compare the closest set of genes 
near poised Sox2 target enhancers in both cell types to gene expression signatures across mouse 
development from the MGI database, and we found that in ESCs, genes linked to poised, Sox2+ 
enhancers are expressed at later stages of early embryonic development, while in NPCs Sox2+ poised 
genes are expressed in later stages of neural development. (Figure 4d, e).  Then, we used GREAT analysis 
to define the  gene ontology categories and pathways to which Sox2-bound enhancers belonged.  This 
revealed that genes bound by Sox2 through enhancers in ESCs are involved in early morphogenesis, axis 
specification, stem cell differentiation, and development of the neural lineage (Figure 5).  In NPCs, Sox2 
bound enhancers are linked to genes involved in neural development.  Genes closest to H3K27Ac+ 
enhancers are involved in NPC identity, and include transcription factors, genes involved in stem cell 
differentiation and neurogenesis, and members of the Cdc42 pathway (Figure 5).  Genes linked to poised 
enhancers tend to be involved in later neural development and the morphogenesis of brain regions such as 
the cerebellum and hippocampus.  They also include regulators of many major signaling pathways in 
neural development, such as the Reelin pathway that is responsible for migration of immature neurons 
during cortical morphogenesis (Honda et al., 2011), and CamKII and NMDA signaling pathways, which 
are involved in the transmission of signals between mature neurons (Wang et al., 2004).  Thus, Sox2 
occupies enhancers linked to genes involved in early developmental steps from the ESC state through the 
NPC state, in which Sox2 supports NPC function through binding to active enhancers and may prime 
certain loci to be expressed upon terminal differentiation though binding poised enhancers. 
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Figure 4 Expression analysis of Sox2 bound promoters.  a. Comparison of number of Sox2-bound 
regions associated with poised (H3K4me1+/H3k27Ac-) enhancers versus active (H3K4me1+/H3K27Ac+ 
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and H3K4me1-/H3K27Ac+) enhancers.  b,c.  Box and violin plots representing gene expression values 
for genes linked to Sox2-bound poised and active enhancers in ESCs (top) and NPCs (bottom).  p-values 
reflect non-parametric Mann-Whitney U test values.  d,e. MGI expression analysis of genes linked to 
poised enhancers in ESCs (top) and NPCs (bottom). x-axis reflects raw binomial p-value of enrichment 
vs. a whole genome background set. 
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Figure 5 GREAT analysis of genes linked to Sox2 bound enhancers.  Classes of genes linked to 
poised (top) and active (bottom) enhancers bound by Sox2 in ESCs (left) and NPCs (right).  x-axis 
reflects raw binomial p-value of enrichment vs. a whole genome background set. 
 
Common targets of Sox2 across development 
 Sox2 was associated with genes involved in neural development and housekeeping functions in 
both cell types, but surprisingly very few regions bound by Sox2 were common between the datasets; 
approximately 9% of regions bound by Sox2 in ESCs were bound in NPCs, and less than 5% of Sox2 
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bound regions were common between ESCs and NPCs (Figure 6a, Table 1).  In spite of this, we sought to 
define any commonalities between these targets to uncover mechanisms by which Sox2 might regulate 
ESCs and NPCs in a similar manner.  In fact, of the few common Sox2 bound regions between ESCs and 
NPCs, many occur within promoter regions (Figure 6b).  Approximately 38% of Sox2-bound regions near 
TSSs in ESCs were also occupied by Sox2 in NPCs.  Further, at the gene level, we see that approximately 
57% of the genes bound by Sox2 in ESCs are also bound by Sox2 in NPCs, including loci where Sox2 is 
bound the same site and loci in which Sox2 is associated with the same gene at different sites in the 
promoter (Figure 6c).  These genes tend to be highly expressed in both ESCs and NPCs (Figure 6d), and 
encode epigenetic and transcriptional regulators, regulators of the cell cycle, and a lowly enriched group 
of regulators of nervous system development (Figure 6e).  Thus, Sox2 regulates a subset of promoters in 
both ESCs and NPCs, sometimes utilizing different binding sites to do so, and these genes encode 
transcriptional, epigenetic, and cell cycle regulators which are involved in housekeeping and development 
of the neural lineage.   
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Figure 6 - Many promoters bound by Sox2 in ESCs remain bound in NPCs.  a. Overlap of all Sox2 
bound regions in ESCs (blue) and NPCs (red).  b. Overlap of Sox2-bound regions within 1 kb of 
annotated start sites in ESCs and NPCs. c. Overlap of genes called bound by Sox2 at promoters, at 
overlapping and distinct sites within 1kb of known TSSs.  d. Box and violin plots representing gene 
expression values for genes linked to Sox2-bound promoters common to both ESCs and NPCs.  p-values 
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reflect non-parametric Mann-Whitney U test values.  e. GOSTAT gene ontology analysis of common 
targets.  Example genes from each category are shown on right. 
 
At enhancers, genome-wide trend of low overlap between Sox2 in ESCs and Sox2 in NPCs hold 
true; less than 4% of Sox2 bound enhancers in ESCs are bound by Sox2 in NPCs (Figure 7a).  
Surprisingly, 43% of genes associated with a Sox2-bound enhancer in ESCs were also associated with a 
Sox2-bound enhancer in NPCs (Figure 7b).  Thus, distinct, cell-type specific enhancers occupied by Sox2 
in ESCs and NPCs were often associated with the same nearest gene.  For example, at the Id2, Pax6, and 
Sox2 loci, Sox2 occupied multiple regions upstream and downstream of the TSS, but these regions 
differed depending on the cellular context (Figure 7c).  When we separated these enhancers based on their 
chromatin state, we found that genes linked to Sox2-bound poised enhancers in ESCs acquired new Sox2 
enhancers in either poised and active states in NPCs (Figure 7c).  Conversely, genes linked to Sox2-
bound active enhancers in ESCs were associated with new Sox2–bound poised or active enhancers in 
NPCs (Figure 7d).  Thus, Sox2 occupied a distinct set of enhancer regions in ESCs and NPCs, but many 
of the genes linked to these enhancers were common between the two cell types. 
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Figure 7 - Differential binding of Sox2 at enhancers in ESCs and NPCs.  a. Overlap of Sox2-bound 
regions associated with enhancers.  b. Overlap of nearest gene to Sox2-bound enhancers. c. Gene plots 
depicting Sox2 ChIP-Seq density at indicated loci (mm8 genome).  Sox2 is associated with the same 
locus but at different sites in ESCs and NPCs in many cases.  y-axis reflects reads per million.  d. Pie 
charts depicting fraction of genes linked to poised (left) and active (right) Sox2-bound enhancers in ESCs 
which become associated with new Sox2-bound poised enhancers, Sox2-bound active enhancers, or no 
new Sox2-bound enhancers in NPCs 
 
Next, we sought to understand the function of genes associated with distinct sets of Sox2-bound 
enhancers in both cell types commonly.  Genes linked to Sox2-poised enhancers in ESCs and NPCs were 
lowly expressed in both cell types (Figure 8a) and tend to code for genes involved in differentiation past 
the NPC state, such as the proneural bHLH transcription factor Math1 and the Lim family homeobox 
transcription factors Lhx5 and Lhx8 (Figure 8b) (Zhao et a., 1999; Gowan et al., 2001; Zhao et a., 2007; 
Miquelajauregui et al., 2010).  Genes which switch from poised, Sox2+ enhancers to active, Sox+ 
enhancers are more highly expressed in NPCs than ESCs (Figure 8a) and encode for regulators of NPC 
function such as EGF receptor and cell signaling molecules involved in the cytoskeleton such as Focal-
Adhesion Kinase (Fak) (Figure 8c) (Reynolds and Weiss, 1992; Brown et al., 2005).  Putative Sox2 
targets through active ESC enhancers are also maintained in NPCs through both poised and active Sox2+ 
enhancers.  Genes which switch from active to poised decrease in expression level from ESCs to NPCs 
(Figure 8a) and include signaling molecules and transcription factors such as Otx2, which is involved in 
both early specification of pluripotent cells to ectoderm and the differentiation of NPCs to specific neural 
subtypes (Figure 8d) (Vernay et al., 2005).  Finally there is a subset of genes associated with Sox+ active 
enhancers in both ESCs and NPCs, which are expressed in both cell types but expressed at a higher level 
in NPCs (Figure 8a).  These genes and encode transcription factors involved in both ESC and NPC 
identity such as Sox2 itself (Figure 8e).  Interestingly, genes associated with active, Sox2+ enhancers in 
ESCs involved in cell migration split into two categories in NPCs, some being linked to active, Sox2+ 
enhancers and other linked to poised, Sox2+ enhancers.  While NPCs must keep cell 
migration/differentiation and cell adhesion/stem cell maintenance in equilibrium to ensure proper 
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development of the CNS, the cells of the ICM do not maintain a pool of themselves as development 
proceeds, and in fact all migrate to new positions in the epiblast and finally in one of three germ layers 
soon after the ICM is formed, suggesting that cell migration pathways might be mostly active in ESCs 
while becoming more sensitively regulated in NPCs.  Our data suggest that Sox2 might be central in 
achieving this balance.  Thus, Sox2 is associated with poised and active enhancer elements in both ESCs 
and NPCs, and in general these enhancers are linked to genes which progressively regulate the 
development of the nervous system. 
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Figure 8 - Characterization of Sox2+ enhancer associated genes.  a. Box and violin plots representing 
gene expression values for genes linked to Sox2-bound enhancers grouped by change or maintenance of 
enhancer state between cell types.  p-values reflect non-parametric Mann-Whitney U test values.  b-e. 
GOSTAT gene ontology analysis of genes in above classes. 
 
Discussion 
In this study, we investigated the genome-wide binding profiles of the HMG-box transcription 
factor Sox2 in two cell types in which it is thought be a master regulator of cell identity:  pluripotent 
embryonic stem cells and multipotent neural precursor cells.  How this master regulator can control 
cellular identity in two distinct stem cell types has been an unsolved question for some time.  In ESCs, 
Sox2 was known to occupy genes involved in ESC identity and lineage commitment factors which would 
become active only later in development, indicating that it could act as a pioneer factor (Liber et al., 
2010).  Recently, analysis of Sox3 in NPCs revealed that a subset of Sox2 target regions in ESCs linked 
to repressed genes involved in neural precursor identity were bound by Sox3 in NPCs (Bergsland et al., 
2011).  This study also suggested that Sox2 may co-occupy many Sox3 bound sites in NPCs.  These 
genes in turn fell into two classes: those which were expressed in NPCs, and those which were repressed 
but destined to be activated later in development.  The latter group was shown to be bound by Sox11 as 
NPCs completed their differentiation towards immature neurons.  Thus, a subset of regulators of nervous 
system development was “handed off” between Sox factors from pluripotent ESC though multipotent 
NPCs, and finally to immature neurons.  This study advanced our understanding of Sox function in neural 
development, but left open many questions, including how Sox2 could function as both an activator of 
transcription at some loci and a pioneer factor at others.  Along those lines, can distinguishing features of 
Sox2-bound regions be identified which differentiate between these two functions? 
To begin to answer these open questions, we performed ChIP-Seq on Sox2 in ESCs and NPCs.  
We confirmed that in ESCs, Sox2 occupied the promoters of genes encoding transcription factors and 
epigenetic regulators.  In NPCs Sox2 also occupied the promoters of genes in these classes, but in 
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addition genes involved in RNA splicing, which is known to play a major role in the development of the 
CNS (Grabowski, 2011).  For example, in NPCs Sox2 occupied the promoters of two splicing factors, 
PTB and nPTB (neuronal PTB), which form a negative feedback switch between non-neuronal (including 
NPC) alternative splicing programs mediated by PTB and neuronal alternative spicing programs mediated 
by nPTB (Boutz et al., 2007).  Our data suggests that the loss of Sox2 in differentiating neurons could be 
a key player in activating this switch, allowing PTB levels to fall which would alleviate the repression 
PTB exerts on nPTB.  We also confirmed that the majority of Sox2 bound regions were distal to known 
TSSs in both cell types, and in support of the notion that these regions might represent distal enhancers, 
we showed that a significant fraction of these non-TSS associated Sox2-bound regions correlate with 
known marks of enhancers, H3K4me1 and H3K27Ac.  Consistent with the idea that Sox2 may act as a 
pioneer factor to prime enhancers for later activation (Wegner et al., 2011), we show that a large number 
of the enhancers are H3K4me1 positive, a mark of poised enhancers, but not H3K27Ac positive, a mark 
of active enhancers. 
Sox2 occupied almost mutually exclusive sites in ESCs and NPCs, yet seemed to regulate some 
similar processes.  How could this dichotomy be achieved?  Upon inspection we found that while Sox2-
bound regions were divergent between ESCs and NPCs, many genes were regulated by Sox2 in both cell 
types.  Indeed when focused on promoter-associated Sox2-bound regions, we found a higher overlap 
between Sox2-bound regions in ESCs and NPCs than that observed among all Sox2-bound regions, and 
further we found a large number of genes which displayed Sox2 binding at distinct sites within the same 
promoter.   This phenomenon was even more pronounced when considering enhancers.  Enhancer 
associated Sox2-bound regions were highly divergent between ESCs and NPCs, but many of the genes 
linked to these enhancers were common to both cell types.  Of particular interest were genes linked to 
poised, Sox2+ enhancers in ESCs which became associated with active Sox2 enhancers in NPCs; these 
genes tended to be highly expressed in NPCs relative to ESCs and be involved in NPC identity, 
confirming the presumed role of Sox2 in ESCs as a pioneer factor and indicating that it indeed “hands 
110 
 
off” targets to itself upon transaction to the NPC state.  Furthermore, a subset of genes linked to Sox2-
bound, poised enhancers in ESCs were associated with new Sox2-bound, poised enhancers in NPCs, and 
tended to code for regulators of later neural development.  Thus, Sox2 acts as a pioneer factor in NPCs as 
well, possibly handing off targets to Sox factors expressed in more differentiated neural cells, such as 
Sox11 or Sox21 (Sandberg et al., 2005; Ferletta et al., 2011).  Therefore, a large number of genes crucial 
for the proper execution of neural development are regulated by Sox2 from early development in 
pluripotent ESCs though the multipotent NPC state, where they are poised to become activated upon the 
proper developmental cues (Figure 9). 
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Figure 9 
 
Figure 9 - Sox2 controls neural development from ESCs to NPCs.  Network diagram of Sox2 bound 
genes in ESCs (left) which are involved in nervous system development and generally repressed in ESCs 
(blue) and remain bound by Sox2 in NPCs (right).  In some cases these genes become active in NPCs 
(yellow), but in others they remain poised to become active in differentiated cells of the nervous system. 
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Methods 
Chromatin Immunoprecipitation 
H3K27me3 NPC ChIP 
ChIP was performed as described (Lee et al., 2006).  Briefly, approximately 5x10
8
 cells were cross-linked 
and chromatin fractions were isolated.  Chromatin was sheared by sonication, whole cell extract (WCE) 
was removed, and ChIP was performed using H3K27me3 and Sox2 antibodies (Millipore 07-449 rabbit 
polyclonal).  ChIP and WCE DNA was then purified and genomic libraries were prepared using the ChIP-
Seq Sample Prep Kit (Illumina 1003473) according to the manufacturers protocol (Illumina 11257047) 
for selecting library fragments between 200 and 350 bp. Samples were run using the GA2X genome 
sequencer (SCS v2.6, pipeline 1.5). 
For all other methods, see Chapter 2. 
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Chapter 3: Conclusions 
The focus of this thesis was the role of the Sry-related, HMG-box containing transcription factor 
Sox2 in embryonic stem cells (ESCs) and neural precursor cells (NPCs).  Sox2 occupied more enhancer 
regions than promoters in both cell types, and did so in a cell-type-specific manner; less than 5% of Sox2 
bound regions are shared in ESCs and NPCs.  While regions of Sox2 binding were distinct, the genes 
associated with these regions were shared.  Interestingly, Sox2 associated with a large subset of 
H3K4me1+, H3K27Ac- negative, so-called “poised” enhancers in ESCs which were linked to genes 
involved in neural development.  Many of these genes were also linked to Sox2-bound enhancers in NPCs 
and fell into two groups: those which were now associated with H3K4me1+/-, H3K27Ac+, so-called 
“active” enhancers and involved in NPC identity, and those which remained poised and were involved in 
differentiation past the NPC state.  Thus, Sox2 may act as a pioneer factor, which sets the stage in ESCs 
for later development down the neural lineage by priming specific genes for later activation.  In NPCs, 
some of these genes become active, while at other loci Sox2 continued to keep genes poised to become 
expressed in differentiated neurons and glia. 
 How can Sox2 bind to totally distinct regions in ESCs and NPCs?  In Chapter 2 I outlined 
experiments attempting to answer this question.  The answer did not lie in the motif used by Sox2 in the 
two cell types, as Sox2 utilized the canonical Sox2 recognition site to bind targets in both ESCs and 
NPCs.  While Sox2 is known to partner with the POU factor Oct4 in ESCs, Oct4 is absent in NPCs.  
Interestingly, other POU factor family members are expressed in NPCs, including Brn1 and Brn2.  These 
factors are co-expressed with Sox2 in neurogenic regions of the brain and were previously thought  to 
play some role in NPC function.  Genome-wide analysis of their binding revealed that they co-occupied 
distal enhancers with Sox2 in NPCs, but showed little overlap with Sox2 at promoter regions.  While 
Brn1, Brn2, and Oct4 all utilized Octamer motifs to bind to genomic targets in ESCs and NPCs, 
Sox2:Oct4 and Sox2:Brn bound regions displayed distinct orientations of Sox and Octamer motifs, 
suggesting that the unique stereochemical interactions between Sox2 and POU factors may play a role in 
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target selection by these modules.  Further, ectopic Brn2 in differentiating ESCs recruited Sox2 to new 
target loci and accelerated neural differentiation.  Thus, the suite of partner factors expressed in a given 
cellular context may influence the function of Sox2 in terms of the genomic loci to which it binds.   
 While this thesis has addressed unanswered questions about the role of Sox2 in ESCs and NPCs, 
many questions remain.  How can Sox2 act as a pioneer in some contexts and actively promoter 
transcription in others?  Sox2 must interact with at least two sets of co-factors to achieve this dual 
function.  Oct4, Brn1, and Brn2 co-localize with Sox2 at both active and poised genomic loci, so 
proteomic studies should be performed to determine which other factors interact with endogenous 
untagged Sox2 in genetically matched ESCs and NPCs and attempts should be made to define distinct 
complexes which localize to poised versus active regions.  A good place to start would be the motif 
analysis presented in Chapter 3 which demonstrates that binding sites for multiple transcription factor 
families occur within Sox:POU bound regions.  The differential binding of other factors may play a key 
role in recruiting co-activators or repressors to specific loci.  Another unanswered question is why 
Sox2:Oct4 and Sox2:Brn modules select different Sox:Octamer composite motifs.  Constructs expressing 
chimeric POU factors containing differing domains from Oct4, Brn1, and Brn2 should be engineered and 
tested for the ability to cooperatively bind with Sox2 at known ESC or NPC specific targets.  This may 
allow for the identification of domains or residues that mediate selection of certain composite 
Sox:Octamer motifs.  Also, it would be interesting to more precisely define the relationship between 
Sox2, the POU factors and chromatin marks H3K4me1 and H3K27Ac at enhancers.  Does the presence of 
these marks allow the cell-type-specific binding of Sox2 and POU factors in ESCs and NPCs?  Or, more 
likely, do these factors recruit the enzymes that catalyze the addition of these modifications to histones?  
What are these enzymes?  If a direct link between the establishment of H3K4me1 and H3K27Ac and the 
binding of Sox2 and POU factor partners could be found, the role of these proteins as pioneer factors 
would become more clear.  Finally, this thesis suggests that combinatorial control of gene expression by 
transcription factor co-binding may be a general phenomenon in development.  This may be one way that 
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the limited number of transcription factors encoded in the mammalian genome (less than 2,000) can 
control the expression of approximately 20,000 genes in the constant state of flux that is the process of 
development, in the 200 adult cell types, and in the face of countless external stimuli.  Thus, only by 
defining these combinatorial interactions can the regulatory network of a cell be truly understood. 
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Synopsis 
 By the amazing process of factor-mediated reprogramming, a fully differentiated cell can be 
completely converted back into a pluripotent, embryonic-stem-cell-like state, termed induced 
pluripotency by the ectopic expression of four transcription factors: Oct4, Sox2, cMyc, and Klf4.  Early 
reprogramming systems were inefficient and highly variable, stymieing efforts to study the mechanics of 
this process.  To circumvent these issues, our lab developed “secondary” reprogramming systems, which 
controlled for heterogeneity introduced by the viral transduction of transgenes; secondary systems 
displayed increased efficiency and reproducibility.   I used such a system to study the effects of two 
variables in the reprogramming process: cell density oxygen tension.  I was able to define optimal 
conditions for each parameter, and show that increases or decreases in cell density from this optimal value 
decreased reprogramming efficiency.  Taken together with other published work, these data suggest the 
balance between cell growth and cell senescence plays a key role in determining reprogramming 
efficiency. 
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Introduction 
 Normal development is unidirectional; cell types with wide developmental potential, such as the 
pluripotent cells of the inner cell mass which are capable of differentiating into the cells of the embryo 
proper, progressively give rise to more specialized cell types with less developmental potential, such as 
tissue stem cells and non-dividing, differentiated cells.  Studies of the frog Xenopus demonstrated that this 
directionality is experimentally reversible by transferring a differentiated, somatic nucleus into an 
enucleated oocyte, which upon activation was able to develop into a fully formed frog (Briggs and King, 
1952; Gurdon, 1962).  This technique, known as somatic cell nuclear transfer (SCNT) or cloning, proved 
that development and differentiation occur by reversible, non-genetic changes, and was later used to 
create cloned mammals, such as Dolly the sheep, even from terminally differentiated and non-mitotic 
cells (Wilmut, 1997; Wakayama et al., 2008; Hochedlinger et al., 2002; Eggan et al., 2004).  Thus, 
development is experimentally reversible by factors contained in the oocyte. 
 While it was possible that hundreds of the factors present in the unfertilized egg where 
responsible for reprogramming the somatic nucleus, it was also conceivable that only a few of these 
factors were sufficient for reprogramming.  In 2006, Takahashi and Yamanka showed that indeed the 
ectopic expression by viral transduction of only four transcription factors, Oct4, Sox2, c-Myc, and Klf4, 
was sufficient to reprogram somatic cells (in this case, mouse embryonic fibroblasts [MEFs]) back into 
pluripotent, embryonic stem cell-like cells, termed induced pluripotent stem cells (iPSCs) (Takahashi and 
Yamanaka, 2006).  Factor-mediated reprogramming was sufficient to generate iPSCs from terminally 
differentiated and non-mitotic cells, and could yield iPSCs which pass the most stringent tests for 
pluripotency, germline contribution and tetraploid complementation (Wernig et al., 2007; Takahashi and 
Yamanaka, 2007; Hanna et al., 2008; Zhao et al., 2008; Kim et al., 2011; Carey et al., 2011).  Thus, four 
factors, Oct4, Sox2, c-Myc, and Klf4 are sufficient to reprogram differentiated cells into a pluripotent 
state. 
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 To gain insight into the mechanism by which factor-mediated reprogramming occurred, technical 
hurdles had to be overcome.  One major challenge was the heterogeneity of viral integrations in 
populations of reprogramming cells, which lead to cell-to-cell variation of factor expression.  To 
circumvent this issue, “secondary” systems were designed to create populations of cells with homogenous 
factor integrations (Wernig et al., 2008) (Figure 1).  In these systems, somatic cells which already 
expressed the reverse tetracyclin transactivator, rtTA, and puromycin resistance genes were transduced 
with tetracycline inducible viral vectors expressing the four factors and induced with the tetracyclin 
analog, doxycycline (dox).  Then, once dox-independent iPSC lines were established, the resulting cells 
were injected into blastocysts to create chimeras.  Puromycin-selected MEFs harvested from these mice 
were then homogenous for viral integrations known to be permissive for reprogramming, and upon 
exposure to dox yielded “secondary” iPS cells.  This system also overcame another obstacle to 
mechanistic studies in reprogramming, that of low efficiency.  While primary iPSC generation had an 
efficiency of 1/1,000, secondary systems reached efficiencies of 2-4% depending on the line (Wernig et 
al., 2008).   It was using this system that we performed analyses on the effect of two parameters on the 
efficiency reprogramming process, starting-cell density and oxygen tension. 
 
 
 
 
 
 
 
120 
 
Figure 1 
 
Figure 1: Schematic of the secondary system for obtaining genetically homogenous populations of 
reprogramming somatic cells (Wernig et al., 2008).  
 
Results 
Reprogramming efficiency is dependent on cell density 
 In order to characterize this new “secondary” system, we sought to define the optimal parameters 
in which reprogramming could occur.  The high oxygen tension experienced by cells brought into culture 
relative to the level of oxygen they experience in vivo is known to have a negative effect on cell viability 
and induce cellular senescence, particularly in MEFs (Parrinello et al., 2003).  To test whether oxygen 
tension had an effect on reprogramming efficiency, we cultured secondary MEFs harboring a GFP 
reporter knocked into the Nanog locus (Nanog-GFP; cell line NGFP2) in 20% oxygen and 5% oxygen 
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with dox for three weeks.   We then withdrew dox for one week to ensure we only scored transgene 
independent lines, and counted the number of GFP-positive colonies under each condition.  Indeed, 
reprogramming efficiency was higher in cultures kept under low oxygen, indicating that cellular 
senescence or another process induced by high oxygen may be detrimental to reprogramming efficiency. 
 
Figure 2 
 
Figure 2: Effect of oxygen tension on reprogramming efficiency.  Equal numbers of Nanog-GFP 
MEFs were plated and cultured at either 5% or 20% oxygen in four independent wells with dox for 3 
weeks and without dox for 1 week, and colonies were scored for GFP visually. * indicates p-value < .05, 
Student’s two tailed, paired T test 
  
We next sought to define the optimal cell density under which reprogramming could occur.  
Mammalian cells in culture are known to respond to cell density by sensing paracrine signals from 
neighboring cells (Pedroja et al., 2009; Hanahan and Weinberg, 2010), so we tested whether we could 
define an optimal density under which reprogramming could occur.  Nanog-GFP secondary MEFs were 
plated at varying cell densities, and reprogramming efficiency was calculated by scoring GFP+, dox-
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independent colonies, as above.  We found that at both very low and very high density, reprogramming 
efficiency was reduced (Figure 3).  We observed that at low densities, plated cells seemed to be non-
proliferative and senescent (data not shown), indicating that paracrine factors secreted by neighboring 
MEFs may support cell growth, and the lack of these signals induces mitotic exit, senescence, and 
decrease reprogramming efficiency.  At high densities, it is likely that contact inhibition, a well 
characterized regulator cell growth (Abercrombie, 1979; Küppers et al., 2010), induced mitotic arrest and 
subsequently decreased reprogramming efficiency.  Thus, an optimal density for reprogramming exists in 
which cells maintain paracrine signaling and are not contact inhibited. 
Figure 3 
 
Figure 3: Effect of cell density on reprogramming efficiency.  Varying numbers of secondary Nanog-
GFP MEFs were plated in wells of a 12-well dish (surface area, 400 mm
2
) in triplicate, cultured with dox 
for 3 weeks and without dox for 1 week, and colonies were scored for GFP visually.  Bars indicate 
number of colonies obtained. 
 
 
 
123 
 
Discussion 
 This appendix summarized experiments attempting to characterize the optimal conditions for 
reprogramming using a “secondary” reprogramming system.  We found that both oxygen tension and 
starting cell density influence the efficiency of iPSC generation as measured by activation of a Nanog-
GFP reporter.  Specifically, high oxygen, and low or high cell density inhibited reprogramming in this 
system.  A commonality amongst these deleterious conditions is that they all are known to inhibit cellular 
proliferation.  The hyperoxic environment in normal cell culture relative to an in vivo setting is known to 
induce of cellular senescence, characterized by an irreversible exit from the cell cycle, in MEFs (Parinello 
et al., 2003; Lanigan et al., 2011).  Dense culture of cells are known to undergo contact inhibition, which 
has long been known to negatively regulate cellular growth in culture (Levine et al., 1965), possibly due 
to the important role density sensing plays in normal development and cancer (Hanahan and Weinberg, 
2010).  On the other extreme of cell density, sparse cultures of MEFs also failed to reprogram.  MEFs are 
known to grow poorly at low density, probably due to a loss of paracrine signaling between neighboring 
MEFs, such as those mediated by TGF-β and extracellular matrix components (Smith and 
Braunschweiger, 1979; Connover, 1989; Postlethwaite et al., 1992; Pedroja et al., 2009).  Thus, three 
separate conditions in which cell proliferation was inhibited resulted in decreased reprogramming 
efficiency.   
Interestingly, work from our lab and others later showed that p53 knockout MEFs reprogrammed 
with higher efficiency than controls (Hong et al., 2009; Li et al., 2009; Kawamura et al., 2009; Utikal et 
al., 2009; Mariόn et al., 2009; Hanna et al., 2009), and that this increased efficiency can be fully 
explained by the increase in cell cycle of p53-null MEFs relative to wild-type MEFs (Hanna et al., 2009).  
Thus, my data and work form others suggest that proliferation is a key component of factor-mediated 
reprogramming.  Factor mediated reprogramming is known to be associated with a near-complete erasure 
of the somatic epigenome and a rewriting of a pluripotent, ESC-like epigenetic state (Guenther et al., 
2010).  This includes remodeling of histone modifications and demethylation of modified bases in DNA 
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itself.    One possible explanation for the link between cell proliferation and reprogramming is the idea 
that a certain number of cell divisions must occur to passively dilute out the somatic epigenetic marks.  
Thus, going forward it would be interesting to test whether active erasure of chromatin and DNA 
modifications is necessary for reprogramming by loss-of-function analyses of the enzymes thought to 
catalyze the removal of these marks, or if by ectopic expression of such enzymes it is possible to 
accelerate reprogramming in a cell-proliferation independent way.  Thus, cell proliferation seems to be 
important for factor-mediated reprogramming, but the mechanistic relationship between these two 
processes remains unclear. 
Methods 
Primary iPSCs were generated and injected in host blastocysts as described (Wernig et al., 2008).  For 
secondary MEF isolation, chimeric embryos were isolated at embryonic day 13.5 and the head and the 
internal organs were subsequently removed.  The remaining somatic tissue was physically dissociated and 
then incubated in 0.5% trypsin in HEPES-EDTA at 37C for 20 minutes, after which cells were 
resuspended in MEF media (DMEM supplemented with 10% Fetal Bovine Serum (Hyclone), 0.001 % β-
mercapto-ethanol (Sigma, M7522)., 100 μM nonessential amino acids (Invitrogen, 11140-050), 2 mM L-
glutamine (Invitrogen, 25030-081), 100 U/mL penicillin, 100 μg/mL streptomycin (Invitrogen, 15140-
122) containing puromycin (2ug/mL) and expanded in low oxygen (5%) for two passages prior to 
freezing for long term storage.  Secondary MEFs used for the described experiments were thawed into 
low oxygen and experiments plated 1-2 passages after thawing into 12-well plates with 2 μg/ml 
doxycycline in ES medium (Chapter 2) for 3 weeks, after which doxycycline was withdrawn for 1 week 
and GFP+ iPSC colonies were scored 
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